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Retroviruses and proto-oncogenes. 
Retroviruses have been isolated from a wide variety of an-
imal species. In their natural hosts, they produce a number of 
pathological syndromes including malignant tumors, fatal proli-
ferative diseases (not necessarily neoplastic), anemias and 
slow degenerative diseases that affect hemapoietic, neural and 
other tissues. Tumors induced by retroviruses can be classified 
as sarcomas, carcinomas, leukemias and lymphomas. As far as tu-
mor induction is concerned, retroviruses may be divided into 
two classes: acutely and nonacutely transforming retroviruses. 
The acutely transforming viruses cause the appearance of a tu-
mor within a few weeks after infection. The nonacutely 
transforming viruses induce tumors slowly; "slow" referring to 
the long latency period between infection and the appearance of 
the disease. 
The nonacutely transforming retroviruses are replication 
competent and possess an RNA genome that contains three dif-
ferent genes: gag, encoding proteins of the viral nucleoid, pol 
encoding reverse transcriptase and env, which encodes proteins 
of the viral envelope. The latter are also present in the host 
cell membrane. All virus-encoded products are required for 
viral replication. The nonacutely transforming retroviruses may 
induce various types of malignancies although they have not ac-
quired a so-called oncogene (i .e. a gene directly responsible 
for tumorigenesis and often for transformation of cultured 
cells). For a long time the pathogenic properties of these 
viruses were enigmatic. After a period of confusing theories 
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and conflicting interpretations the following conclusions are 
now generally accepted. 
A virus particle is able to infect cells which express a 
particular type of receptor protein on their cell surface that 
is recognized by the main viral env protein, such as gp70. 
Therefore, gp70 determines the organ tropism of a virus strain. 
In infected animals, the organ tropism may undergo changes when 
new gp70 molecules arise as a result of recombinations between 
the pathogenic virus and so-called endogenous usually nonpatho-
genic viruses. 
In each newly infected cell, the viral genome is integrated 
somewhere in the cellular genome. Viral regulatory sequences, 
especially viral promoters and enhancers, may influence the ex-
pression of genes in the neighborhood of the integration site 
(promoter or enhancer insertion). This is called cis-
activation, because it is limited to the chromosome that con-
tains the integrated viral element. When, in this way, a 
proto-oncogene (see below) is activated, the cell may become a 
malignant cell. The long and variable periods of latency re-
flect the fact that such a malignant activation is a rare event 
in any one cell but likely to happen sometimes in an organism. 
Alternatively, integrated viruses may activate cellular genes 
through so-called trans-activation, i .e. via a soluble factor 
whose action is not limited to the site of integration. The 
mechanism is not yet well understood. The pathogenicity of HIV 
for example is thought to involve such trans-activation through 
the action of the tat gene (trans-activating transcriptional 
gene) of the virus (Wong-Staal and Gallo, 1985; Greene et al, 
1986). 
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The acutely transforming retroviruses lead to transformation 
within a relatively short period after infection. In contrast 
to nonacutely transforming retroviruses, they transform cells 
both in vitro and j_n vivo. The initiation and maintenance of 
neoplastic transformation induced by acutely transforming 
viruses are caused by the products of viral oncogenes present 
in these viruses. In almost all cases, the oncogenes replace 
viral genes necessary for replication, with the consequence 
that the acutely transforming retroviruses are replication de-
fective and need helper virus for their propagation. The viral 
oncogene (v-onc) of the acutely transforming retroviruses is 
the result of a recombination between the genomes of nonacutely 
transforming retroviruses and proto-oncogenes (c-onc) (Fish-
inger, 1982; Bishop, 1983). As a consequence of this recombina-
tion, the transforming potential of proto-oncogenes is mobil-
ized. Apparently, such recombination events have taken place in 
one of the many tumor cells after cis-activation of a cellular 
proto-oncogene by a nonacutely transforming retrovirus. 
Because of the effect of viral oncogenes on regulation of 
cell growth and differentiation and because of the conservation 
of oncogene sequences during evolution, it is reasonable to as-
sume that proto-oncogenes have important functions in normal 
cellular processes. The normal cellular functions of the 
proto-oncogenes may sometimes be disturbed. This can be caused 
by somatic changes within these genes such as point mutations, 
translocations, gene amplifications or insertions. Interesting-
ly, such genetic changes are frequently found in naturally oc-
curing malignancies suggesting a relationship with these 
diseases. For an extensive review on retroviruses, viral on-
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cogenes and proto-oncogenes see: R- Weiss et al (1984). 
With respect to their biological activity, the proto­
oncogene products can be divided into several classes such as: 
cytoplasmic tyrosine phosphokinases (e.g. c-abl, c-fes), poten­
tial kinases (e.g. с-mos, c-raf), GTP-binding proteins (c-ras), 
DNA-binding proteins (e.g. c-myc), growth factors (c-sis) or 
receptors (c-erbA, c-erbB and c-fms). For the products of some 
of the proto-oncogenes, the biological activity is not esta­
blished yet (e.g. c-rel) (Hunter, 1984). The observation that 
proto-oncogene products constitute or resemble growth factors 
and growth factor receptors is of particular interest. The re­
lation between c-sis and a growth factor was established when 
the deduced amino-acid sequence of the v-sis oncogene was shown 
to exhibit a high degree of homology with the incomplete se­
quence of platelet-derived growth factor chain 2 (PDGF-2) (Deu­
el et al, 1983; Doolittle et al, 1983; Waterfield et al, 1983). 
Other studies revealed that the gene products of the (proto-) 
oncogenes, c-fms, c-erbA and v-erbB constitute or resemble the 
receptor for colony stimulating factor-1 (CSF-1) (Sherr et al, 
1985), thyroid hormone (Sap et al, 1986; Weinberger et al, 
1986) and epidermal growth factor (EGF) (Downward et al, 1984), 
respectively. These examples suggest that the products of 
proto-oncogenes are integrated components of signal transduc­
tion systems and as such play an important role in processes 
that control cell growth and differentiation. It is, therefore, 
not difficult to imagine that their malfunctioning could lead 
to derailment of normal cell proliferation and tumorigenesis. 
In the studies described in this thesis, attention is focussed 
upon the c-sis proto-oncogene. 
14 
Growth factors and tumorigenesis. 
Part of our knowledge on cell growth in vivo and the signals 
controlling these processes has been derived from studies on 
established cell lines. Often these cultured cells require 
serum in their media for their propagation. Serum can be re­
placed by specific polypeptides, called growth factors (Barnes 
and Sato, 1980). Growth factors regulate cell proliferation 
through binding to specific cell membrane receptors (Heldin and 
Westermark, ідЗД). They are present in a variety of tissues and 
are released by many cells in culture (Massagué, 1985; Nilsson 
et al, 1985; Rail et al, 1985). The fine tuning of prolifera-
tion rates necessary for coordinated growth of various cell 
types to form and maintain tissues might be due to the great 
diversification of growth factors, the receptor dependent cell 
type specific action of these factors and the requirement of 
multiple growth factors for stimulation of a specific cell 
(Barnes and Sato, 1980; Walthall and Ham, 1981; Tsao et al, 
1982; Heldin and Westermark, 1984; Weinberg, 1985; Goustin et 
al, 1986). 
Cell growth, however, is not necessarily under control of 
positive regulating forces alone. For example, exogenous tumor 
growth factor-ß (TGF-ß) inhibits the growth of many cell types 
including neoplastic cells. Failure to express or respond to 
specific growth inhibitory factors that are released by cells 
to regulate orderly growth may also lead to disorders. There 
may be various possible causes of such a failure, including mu-
tation or loss of the structural gene for TGF-ß itself, loss of 
positive transcriptional or translational controls for expres-
sion of TGF-ß or defects in the specific cellular receptor for 
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TGF-3. This alternative view, called "the Yin-Yang theory of 
cancer", inspired research on cloning tumor-suppressor genes to 
gain more information to support this theory (Massagué, 1985; 
Sporn and Roberts, 1985; Marx, 1986). 
In some cases, growth factors have been shown to increase 
the transcription of proto-oncogenes, such as myc and fos, the 
products of which in their turn may regulate the transcription 
of other genes necessary for stimulation of cell proliferation 
(Cochran et al, 1984; Kruijer et al, 1984; Müller et al, 1984). 
These data suggest that many, if not all, of the oncogenic pro-
ducts may be involved in the pathway that follows the binding 
of the growth factor to its receptor. At each step of this 
pathway alterations may occur leading to the development of 
neoplastically transformed cells. A possible scenario of the 
sequence of events, that follow the binding of the growth fac-
tor to its receptor and lead to a cellular response can be out-
lined as follows (Figure 1): 
* A growth factor binds to its cell surface receptor. After 
this step, the receptor may undergo allosteric changes, a 
redistribution in the membrane or an association with other 
membrane proteins. For example, the platelet-derived growth 
factor (PDGF) receptor consists of a PDGF binding domain, a 
transmembrane region and a cytoplasmic part that is able to 
bind adenosine triphosphate (ATP) and substrate(s) for phos-
phorylation (Frackelton et al, 1984; Daniel et al, 1985). In 
presence of PDGF, the receptor density on the cell surface 
decreases ("down-regulation") as the PDGF-receptor complex 
is internalized (Heldin et al, 1982; Nilsson et al, 1983). 




Figure 1. A possible mechanism of the influence of growth fac­
tors or tumor promoters on cellular responses. For a detailed 
description see text. Abbreviations: GF, growth factor; TP, tu­
mor promoter; PIP2-specific PDE, phosphatidylinositol-4,5-
bisphosphate-specific phosphodiesterase; DAG, diacylglycerol; 
IP_, inositol trisphosphate; E.R., endoplasmic reticulum; CaM, 
calmodulin; PC-specific PL-C, phosphatidylcholine-specific 
phospholipase C; PCho, phosphocholine; ATP, adenosine triphos­
phate; ADP, adenosine diphosphate; GTP, guanosine triphosphate; 
GDP, guanosine diphosphate. 
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sence of growth factor. Sequence homology between the viral 
oncogene v-erbB and the cellular receptor for EGF indicated 
that the main difference between the two is the absence of 
the EGF-binding domain in the viral oncogene product (Down­
ward et al, 1984). Transformation by ν-erВ could therefore 
involve a mechanism in which the v-erbB protein relays a mi-
togenic signal even in the absence of growth factor binding. 
* The activated growth factor receptor may transmit informa­
tion through the plasma membrane into the cell by means of a 
family of G proteins: membrane proteins that are activated 
by binding guanosine triphosphate (GTP). Because of its lo­
cation in the plasma membrane, its GTP-binding capacity and 
its involvement in the phosphatidylinositol-4,5-bisphosphate 
(PIP-) breakdown pathway (see Figure 1 and below), the pro­
duct of the ras proto-oncogene resembles a G protein 
(Fleischman et al, 1986). 
The G protein activates an "amplifier" enzyme on the 
inner surface of the membrane. This enzyme converts precur­
sor molecules into second messengers. In the cascade follow­
ing binding of PDGF to its receptor, an "amplifier" enzyme 
is PIPp-specific phosphodiesterase (PIPp-specific PDE) which 
cleaves PIPp into the second messengers inositol trisphos-
phate (IP,) and diacylglycerol (DAG) (Berridge, 1984a, 
1985). 
Addition of a tumor promoter (e.g. phorbol dibutyrate = 
PBT ) to cells results in increased concentrations of DAG 
and phosphocholine (PCho), which is due to the activation by 
protein kinase С of phosphatidylcholine-specific phospholi-
pase С (PC-specific PL-C). The observation that PDGF and 
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serum leads to the degradation of phosphatidylcholine into 
DAG and PCho, although the activation of protein kinase С is 
blocked, indicates that PDGF and serum act through a mechan­
ism independent of protein kinase C. This is in contrast 
with PBT?, which stimulates phosphatidylcholine hydrolysis 
in a manner solely dependent on protein kinase С (Besterman 
et al, 1986; Pasti et al, 1986). 
The second messengers activate cellular proteins by inducing 
conformational changes. One of the second messengers of the 
PIP- pathway is IP-. Increased concentrations of IP- lead to 
a rapid release of calcium from an intracellular vesicular 
pool. The IP_-sensitive calcium site of release is the endo­
plasmic reticulum and not the mitochondria as was concluded 
from cell fractionation and inhibition experiments. The 
release of calcium leads to phosphorylation of various pro-
2+ 
teins through the action of activated Ca /Can protein 
kinase (CaM: calmodulin) and, in this way, contributes to 
the cellular response on the binding of a growth factor to 
its receptor (Berridge, 1984a, 1985). 
The other second messenger of the PIP- system is the mem­
brane bound DAG, which activates protein kinase C. Protein 
kinase С is capable of phosphorylating cytoplasmic proteins 
and causes alkalization of the cytoplasm by activation of a 
Na /H exchange carrier, resulting into several physiologi­
cal processes (Berridge, 1984a, 1985). 
PDGF stimulation of quiescent cells is thought to follow one 
the pathways described above leading to the phosphorylation 
a large number of proteins as a consequence of protein 
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2+ kinase С and Ca /CaM protein kinase activation (Berridge et 
al, 1984b; Ek and Heldin, 1984). Binding of PDGF to its recep­
tor causes also a rapid reorganization of the cytoskeleton ac­
tin and vinculin (Mellstrom et al, 1983; Burn et al, 1985; Her­
man and Pledger, 1985; Lassing and Lindberg, 1985). Evidence is 
provided for an interplay between PIP and DAG with the poly­
merization and membrane interaction of actin and oc-actinin 
respectively. It was shown that PIPp causes a rapid and effi­
cient dissociation of profilactin with a concomitant polymeri­
zation of actin (Lassing and Lindberg, 1985). In vitro, a tight 
complex, displaying substructures similar to those of microfi­
lament bundles in vivo, is formed between ct-actinin, DAG and 
one fatty acid of a certain type (for example, palmitic acid) 
(Burn et al, 1985). These observations suggest a relationship 
between the increased activity in the PIP? cycle seen as a 
result of ligand-receptor interaction and the induction of ac­
tin filament formation. 
Because the pathway of the signal transduction described 
above is very complex, it is conceivable that aberrations in 
this sequence of reactions can occur and might lead to abnor­
malities in cellular growth. 
Platelet-derived growth factor (PDGF). 
PDGF is contained in α-granules of platelets and is released 
during blood clotting or when platelets adhere at sites of 
blood vessel injury. PDGF may serve to promote wound healing 
since it is the most potent mitogen in serum for cells of 
mesenchymal origin, including fibroblasts, glial cells and 
smooth muscle cells. Because of its mitogen activity, PDGF may 
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also be involved in the formation of atherosclerotic lesions 
(Stiles, 1983; Deuel and Huang, 1984; Ross et al, 1986). Pla-
telets are not the only cell type that release PDGF-like pro-
teins; cultured rat aortic smooth muscle cells, human glioma 
cells, human sarcoma cells, human osteosarcoma cells, activated 
macrophages, cultured bovine endothelial cells, SSV-transformed 
cells (SSV: simian sarcoma virus) and activated human monocytes 
also produce such growth factors (Martinet et al, 1986; Ross et 
al, 1986). 
Human PDGF is purified from platelets and biochemically and 
physiologically characterized. The major species are PDGF-I 
(31-35 kda) and PDGF-II (28-32 kda); they are equally active in 
bioassays, radioreceptor assays and radioimmuno assays but 
differ in their carbohydrate composition (Antoniades, 1981; 
Deuel et al, 1981; Huang et al, 1982). Reduction of PDGF 
results in loss of biological activity. The result of high-
performance liquid chromatography experiments with reduced and 
alkylated PDGF suggested also that PDGF was a two-chain 
molecule. A heterogeneous PDGF-1 fraction (chain A; major form 
18 kda) and a homogeneous PDGF-2 fraction (chain B; 16 kda) 
were found and the two chains appeared to be related to each 
other (Johnsson et al, 1982). These results led to the conclu-
sion that PDGF might be a heterodimer consisting of one PDGF-1 
and one PDGF-2 chain. However, Heldin et al (1986) recently 
isolated a PDGF-like growth factor resembling a homodimer of 
PDGF-1. This PDGF-like growth factor was isolated from a human 
osteosarcoma cell line and had structural, functional and immu-
nological characteristics in common with PDGF isolated from hu-
man platelets (Heldin et al, 1980). The two chains of human 
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PDGF (PDGF-1 and -2) are encoded by genes which are located on 
different chromosomes (7 and 22 respectively) (Pavera et al, 
1982; Betsholtz et al, 1986). Screening of human tumor cell 
lines with specific probes for these two chains revealed that 
both genes are expressed independently. Immunoprecipitation of 
PDGF-like growth factors from conditioned medium of these cell 
lines correlates with the expression of PDGF-1 but not with 
that of PDGF-2, suggesting that all of the PDGF-like factors in 
these media are composed of only PDGF-1 chains (Betsholtz et 
al, 1986). Homodimers of both PDGF-1 and -2 chains are capable 
of binding to the PDGF receptor and exhibit mitogen activity 
(Heldin et al, 1980, 1986; Kelly et al, 1985). Therefore, the 
exact nature of the human PDGF subunit composition is still 
unknown. 
PDGF receptor. 
Several cell lines were shown to possess the capability of 
binding PDGF: human osteosarcoma cell lines, human fibroblasts, 
glial cells, smooth muscle cells and mouse 3T3 cells (Heldin et 
al, 1981, 1982; Bowen-Pope and Ross, 1982; Graves et al, 1984a, 
1985; Williams et al, 1984). 
The PDGF receptor is a 180 kda membrane glycoprotein, with 
an associated tyrosine-specific protein kinase activity. A less 
pronounced phosphorylation of a 130 kda protein was also no-
ticed after binding of PDGF to its receptor. This 130 kda com-
ponent is a proteolytic cleveage product of the 180 kda 
glycoprotein (Ek et al, 1982; Heldin et al, 1983; Frackelton et 
al, 1984; Daniel et al, 1985). 
The genomic structure of the PDGF receptor has been charac-
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terized using cDNA cloning (Yarden et al, 1986). From the de-
duced amino-acid sequence of the PDGF receptor it appeared that 
the structure of the receptor is closely related to the v-kit 
oncogene product and the receptor for the macrophage colony 
stimulating factor CSF-1, which is encoded by c-fms. Compared 
to the EGF receptor, an insertion is present in the kinase 
domain of v-kit, the PDGF and CSF-1 receptor. The cysteine 
residues in the extracellular domain of the PDGF receptor show 
a similar distribution pattern as those in the CSF-1 receptor 
(Yarden et al, 1986). 
Binding of PDGF to its receptor leads to a rapid internali-
zation of the factor via small vesicles. Because the internali-
zation is followed by a tempory loss of the ability of the 
cells to bind the ligand ("down-regulation"), the latter is 
probably ingested as a receptor-ligand complex (Pastan and Wil-
lingham, 1981; Huang et al, 1982; Nilsson et al, 1983). After 
PDGF binding, several "immediate" and "early" events can be 
monitored. Some "immediate" events, which are independent of 
RNA synthesis, are: tyrosine-specific phosphorylation, stimula-
tion of phosphatidylinositol turnover and reorganization of ac-
tin filaments (Ek et al, 1982; Berridge, 1984b; Herman and 
Pledger, 1985). Examples of "early", transcriptionally depen-
dent events are: induction of transcription of genes among 
which c-fos and c-myc, presence of unique proteins and division 
of cells without further requirement of PDGF (Rutherford and 
Ross, 1976; Pledger et al, 1981; Olashow and Pledger, 1983; 
Cochran et al, 1984; Kruijer et al, 1984; Müller et al, 1984). 
Because of the homology of the amino-acid sequence of PDGF-2 
with the predicted amino-acid sequence of the transforming pro-
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tein encoded by the v-sis oncogene of SSV and the inhibition of 
acute transformation by SSV using antibodies against PDGF 
(Pavera et al, 1981; Wong-Staal et al, 1981; Bobbins et al, 
1982; Doolittle et al, 1983; Waterfield et al, 1983; Johnsson 
et al, 1985a), it was of interest to define further the c-sis 
proto-oncogene and the sequences controlling its expression. 
The зіз proto-oncogene. 
The human c-sis proto-oncogene is located on chromosome 22 
(qll.qter) (Goyns, 1983; Groffen et al, 1983). Human chromo­
somes 22 and 9 are implicated in the chromosome translocation 
(t(9,22) (qS^ql 1 ) ), observed in an Ewing-Sarcoma cell line and 
in patients suffering from chronic myeloid leukemia (CML) 
(Goyns, 1983-; Grof fen et al, 1983; Geurts Van Kessel, 1985). 
The sis proto-oncogene is translocated to chromosome 9 and the 
abl proto-oncogene to chromosome 22 leading to the Philadelphia 
chromosome (Groffen et al, 1984). The results that no sis mRNA 
transcripts but, instead, altered c-abl transcripts fused with 
the ber gene were observed led to the conclusion that the c-sis 
proto-oncogene was not involved in the formation of these tu­
mors (Bechet et al, 1984; Heisterkamp et al, 1985; Shtivelman 
et al, 1985). 
Transcription of the sis proto-oncogene is observed in 
several cell types: endothelial cells, HeLa cells, osteosarcoma 
cell line, prostatic carcinoma cell line, glioblastoma cell 
line, activated monocytes, lung tumor cell line, placenta, neu­
roblastoma cell line (Barrett et al, 1984; Graves et al, 1984b; 
Goustin et al, 19&5; Van den Ouweland et al, 1985, 1986, 1987; 
Van Zoelen et al, 1985; Martinet et al, 1986). As the main 
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transcriptional product in human cells, an mRNA species of 
about 3.5 kb with a coding potential for a protein of about 27 
kda , the sequence of which shows strong homology with PDGF-2, 
was described (Collins et al, 1985; Ratner et al, 1985; Rao et 
al, 1986). Because of the striking difference between the size 
of the v-sis oncogene (1 kbp) and the mRNA transcribed of the 
c-sis proto-oncogene (3·5 kb) it is clear that the complexity 
of the c-sis proto-oncogene is greater than the v-sis homolo-
gous sequences (Devare et al, 1983; Van den Ouweland et al, 
1986). 
As mentioned above, the c-sis proto-oncogene may be involved 
in differentiation and transformation. Jay et al^  (1985) have 
shown that during endothelial cell differentiation _in vitro ex-
pression of the sis gene was modulated. Transformed cells ob-
tained upon transfection with cDNA or cloned genomic DNA of the 
sis locus were morphologically identical to those observed upon 
transfection with the viral oncogene v-sis, suggesting that no 
changes such as point mutations were required for transforma-
tion (Clarke et al, 1984; Gazit et al, 1984). Antibodies 
against PDGF were used in an attempt to identify the transform-
ing product in the transfection assays with SSV. The presence 
of anti-PDGF antibodies appeared to inhibit both proliferation 
and SSV-induced morphological changes in human fibroblasts, 
suggesting that SSV-transformation is due solely to the auto-
crine action of a PDGF agonist. Despite a continuous expression 
of the viral genome and production of a PDGF-like factor lead-
ing to a "down-regulation" of the PDGF receptor the SSV-
transformed cells at high passage level revert phenotypically. 
These data give reason to believe that SSV-transformed cells 
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and their normal counterparts senesce by the same mechanism in-
volving a block in the post-receptor pathway. Taken together, 
these data indicate that SSV-transformation must be mediated by 
a growth factor that mimics PDGF (Huang et al, 1984; Johnsson 
et al, 1985a, 1985b, 1986). 
This thesis describes the moleculary cloning and characteri-
zation of the human and feline c-sis proto-oncogenes and their 
flanking sequences. To gain more insight in the regions that 
have regulatory functions involved in the expression of the c-
sis proto-oncogene, a good characterization of this gene is 
necessary. As already described, the simian sarcoma virus has 
captured only limited sequences from its cellular counterpart 
and, therefore, the viral oncogene can not be used to define 
the entire c-sis proto-oncogene. Taken into account the con-
served nature of the proto-oncogenes (R. Weiss et al, 1984), 
comparative analysis of the c-sis proto-oncogenes of two 
species could lead to a complete description of the gene. The 
species used in this thesis are human and cat. The latter was 
chosen because of the existense of a v-sis homologous sequence 
present in the Parodi-Irgens strain and the great knowledge of 
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Feline and human genetic sequences, homologous to the \-sis gene of simian sarcoma virus, have been 
isolated from cosmid gene libraries and characterized by restriction endonuclease analysis. Comparison of 
the two loci revealed their related structural organization. In both loci, similar unique genetic sequences were 
found upstream of the \-sis homologous region and these hybridized to a 4.2 kb c-sis transcript in human 
lung tumor cells. These data establish and map as yet unidentified coding sequences at the 5' part of the c-sis 
proto-oncogene of both species. 
Introduction 
It is well estabbshed that viral oncogenes of 
acutely transforming RNA tumor viruses have 
arisen by recombination between retroviral ge-
nomes and genetic sequences of cellular origin 
[1-3] These cellular sequences, which are highly 
conserved during evolution, are known as proto-
oncogenes In their normal form, they are thought 
to have an important function during growth and 
differentiation [4-7] It has also been suggested 
that proto-oncogenes are involved in tumongene-
sis [8-11] In that case, however, genetic changes 
such as point mutations [12], translocations [13] or 
insertions [14] seem to be required Some viral 
oncogenes code for proteins that have been identi-
* To whom correspondence should be addressed 
Abbreviations RFLP, reslnclion fragment length polymor-
phism ALL, acute lymphocytic leukemia, SSV simian sarcoma 
virus PI FeSV Parodi-lrgens feline sarcoma virus FeLV feline 
leukemia virus 
fied and charactenzed as a protein kinase capable 
of phosphorylating tyrosine residues [15,16], a 
growth factor [17,18] or a growth factor receptor 
[19] 
The proto-oncogene under investigation in the 
present study is c-sis Genetic sequences from this 
locus have been captured in the genome of 
Parodi-lrgens feline sarcoma virus (PI-FeSV), iso-
lated from a fibrosarcoma of a cat infected with 
feline leukemia virus (FeLV) [20], and simian 
sarcoma virus (SSV), isolated from a fibrosarcoma 
of a woolly monkey [21] Their transforming pro-
teins have been identified as a 76 kDa fusion 
protein containing gag and sis genetic sequences 
[22] and 28 kDa protein [23-25], designated p28s,s, 
respectively Recently, comparison of amino acid 
sequences of human PDGF-2 with preaicted se-
quences of p28sl!' has shown that these proteins 
share a virtually identical region [17,18,25] In the 
light of the fact that in certain human tumors 
transcripts have been found that are related to 
v-sis [26,27] and that a number of human tumors 
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produce PDGF-like proteins [28,29], it is of inter­
est to investigate the potential involvement of the 
sis locus in tumongenesis As a first approach, 
studies were focussed upon the isolation and char­
acterization of this locus and its flanking cellular 
sequences The size of the viral oncogene in SSV is 
about 1 kbp [23,24,30] and homologous transcripts 
found in human tumor cell lines are about 4 2 kb 
and 2 7 kb in size [27] This could indicate that 
the human c-sis locus contains more genetic se­
quences than those homologous to v-sis To re­
solve this, we have molecularly cloned the human 
and feline c-sis proto-oncogenes for comparative 
analysis and have performed Northern blot analy­
sis of c-sis transcripts in human tumor cells 
Materials and Methods 
Cosmid, phages, plasmids and E coli strains 
pC60, a recombinant of pBR322 containing the 
entire SSV provirus [31], was a gift from R С 
Gallo FAOl and FA02 represent subclones of 
pC60 in phage vector ml3mp8 They contain the 
0 5 kbp Sac\/Sma\ or the 0 5 kbp Smal/Xbal 
restriction fragments of pC60, respectively Both 
fragments together represent almost the complete 
v-sis oncogene Restriction endonuclease S a d 
cleaves the oncogene at nucleotide position 22 and 
Xbal just before the last nucleotide of L-SIS 
BamHl linkers were used in preparation of the 
subclones 
pAO70, pA073, pA079 and р А О Ш are sub­
clones of the human c-sis locus (see also Fig 3) 
pAO70 consists of a 5 0 kbp tfmdIII DNA frag­
ment subcloned in pSVBR94 An internal 3 8 kbp 
Kpnl/Kpn\ fragment of this insert was used as a 
molecular probe pA073 and pA079 are recombi­
nant clones of pBR322 containing respectively an 
1 7 kbp BamH\ and an 1 3 kbp Ba/wHI/WindlII 
restriction fragment A 2 0 kbp EcoRI/T/mdIII 
restriction fragment was subcloned in pUC18 re­
sulting in pA0121 
E coli strain HB101 (hsdR~, recA") was used 
as a host for pC60, pAO70, pA073, pA079 and 
р А О Ш E coli strain 1046 (supE, supF, hsdS", 
recA") was used for preparing the pJB8 [32] 
cosmid libraries The recombinant ml3mp8 
bacteriophages FAOl and FA02 were propagated 
in E coli strain JM101 [33] 
Preparation of DNA probes and hybridization 
Preparation of DNA probes and their mck 
translation [34] was earned out as described before 
[35] Pnmer extension reactions were according to 
Messing and co-workers [33] The specific activity 
of the probes used in the hybridization studies was 
(2-5) 10B cpm/yg Agarose gel electrophoresis, 
Southern blot [36] and hybridization analysis was 
performed as desenbed before [35] 
Molecular cloning of c-sis sequences 
The human and feline \-sis homologous genetic 
sequences were isolated from previously con­
structed cosmid gene libraries [35,37] High-molec-
ular-weight DNA used for the construction of the 
cosmid gene libraries was prepared from blood 
cells of a patient suffering from a common type 
acute lymphocytic leukemia (ALL, patient No 
1283) and from lung tissue of a domestic cat 
Southern blot analysis of DNA isolated from the 
leukemia patient indicated that the c-sis proto­
oncogene of this patient was similar in structure to 
that found in normal human liver DNA (data not 
shown) and, thus, the previously constructed 
library was suitable for the isolation of the c-sis 
proto-oncogene 
RNA isolation and Northern blotting 
Total cellular RNA was isolated according to 
the guamdine-thiocyanate procedure described by 
Feramisco et al [38] Upon poly(A) selection by 
oligo(dT)-cellulose chromatography, RNA was 
dissolved in sodium phosphate buffer (25 mM, pH 
6 5), which contained DMSO (50%) and glyoxal 
(0 5 M), and heated to 50 o C for 1 h RNA was size 
fractionated by agarose gel electrophoresis (1 4% 
agarose gel) and transferred to nitrocellulose for 
hybridization analysis as desenbed before [39] 
Results 
Analysis of genetic sequences homologous to v-sis in 
human and feline genomic DNA 
For analysis of the size and distnbution of 
genetic sequences in human and feline genomic 
DNA homologous to \-sis two -іи-specific 
probes, FAOl and FA02 were used These probes 
contained the 5' and 3' half of the viral oncogene 
as described under Materials and Methods Hu-
36 
man DNA, isolated from the ALL patient (No. 
1283) and digested with restriction endonuclease 
HindlU (Fig. 1, lane 1), revealed a hybridizing 
fragment of about 23 kbp. A similar analysis of 
DNA isolated from blood cells of a normal in­
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Fig. 1. Identification of genetic sequences in human and feline 
cellular DNA homologous to v-sis. High-molecular-weight 
DNA was prepared from blood cells of a patient suffering from 
a common type acute lymphocytic leukemia (patient N o l 283) 
(lane 1) and blood cells of a normal individual (lane 2) or from 
lung tissue of a domestic cat (cat No. 03U82) (lane 3), digested 
with restnction endonuclease //indili (lane 1 and 2) or £coRI 
(lane 3) and size-fractionated by agarose gel electrophoresis 
through an 0.1% agarose gel. Upon transfer of the DNA to 
nitrocellulose, hybridization analysis was performed with P-
labeled probes (FAOl and FA02) representing almost the 
complete v-sis oncogene. Molecular weight markers included 
are ///ndlll-digested λ DNA fragments. 
fragments of about 23 kbp, 17 kbp and 5.7 kbp 
(Fig. 1, lane 2), indicating the presence of a Я ; ^ І І І 
restriction fragment length polymorphism (RFLP). 
Among 10 human DNA preparations tested in this 
way, 6 had the same Hmdlll RFLP in one allele, 
but none of the DNAs showed the HindlU RFLP 
in both alleles (data not shown). Southern blot 
analysis of DNA of ALL patient No. 1283 with 
restriction endonuclease £coRI revealed a single 
hybridizing fragment of about 25 kbp, and with 
restriction endonuclease Xbal, three v-sis homolo-
gous DNA fragments of about 25 kbp, 8.4 kbp 
and 3.6 kbp were identified (data not shown). 
Southern blot analysis of high-molecular-weight 
feline DNA (cat No. 031182) with FAOl and 
FA02 is shown in lane 3 of Fig. 1. Two £coRI 
hybridizing fragments could be identified. One 
was about 8 kbp in size and the other 4.3 kbp. 
Southern blot analysis with restriction endo-
nuclease BamHI revealed a 13 kbp, a 4.8 kbp and 
an 1.3 kbp v-sis homologous DNA fragment (data 
not shown). Similarly, DNA fragments of about 25 
kbp, 5 kbp and 2.6 kbp were found using restric-
tion endonuclease Hmdlll (data not shown). 
These results indicate that in both species the 
v-sis homologous genetic sequences are distributed 
discontinuously over a relatively large region. Sim-
ilar observations have previously been reported for 
the human locus [40-42]. Furthermore, in view of 
the fact that the viral oncogene of SSV seems to 
represent only a minor portion of the human 
cellular locus, the size of the complete proto-
oncogene could be much greater. 
Molecular cloning of human and feline c-sis genetic 
sequences 
Based upon the results described above, we 
have used a previously described human and feline 
cosmid gene library to isolate from both species a 
large contiguous DNA region that contained the 
c-sis proto-oncogenes. Screening of the human 
cosmid gene library (300000 colonies) with the 
v-i/i-specific probes FAOl and FA02 resulted in 
one c-sis containing cosmid clone (ALLW-1283-
C121) as is shown in Fig. 2A, lane 1 and Fig. 2B, 
lane 1, ALLW-1283-C121 contained all human v-sis 
homologous sequences as detected in genomic blot 
analysis (hybridization data not shown). A restric-
tion map of this clone was obtained on the basis of 
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Fig. 2. Charactenzalion of cosmid clones isolated from a human and feline cosmid gene library. (A) DNA of cosmid clones 
ALLW-1283-Cm (lane 1). MBIO (lane 2). MB25 (lane 3) and feline cosmid clones MB65 (lane 4) and MB70 (lane 5) was digested 
with restnction endonuclease Hindlll (lanes 1. 2 and 3) or with £coRI (lanes 4 and 5). size-fractionated by agarose gel electrophoresis 
(0.6% agarose gel) and visualized by ethidium bromide staining. (B) Southern blot analysis of human cosmid clones ALLW-1283-C121 
(lane 1). MBIO (lane 2), MB25 (lane 3) and feline cosmid clones MB65 (lane 4) and MB70 (lane 5) with v-iu-specific molecular probes 
FAOl and FA02 Digestion with restnction endonucleases is as descnbed under A. Cosmid clones MBIO and MB25 were isolated by 
'chromosome walking" (see Fig. 3) using the insert of pA079 as a probe. Molecular weight markers were as descnbed m the legend to 
Fig. 1. 
restriction endonuclease digestion patterns using 
the restriction endonucleases SamHI, £coRI, 
Я/ndIII, Kpnl, Xbal and ATioI or combinations 
of these in sequential digestions (data summarized 
in Fig. 3). The onentation of c-sis sequences of 
ALLW-1283-C121 was obtained by hybridization 
analysis using FACI or FAOl as a 5' or 3' v-sis-
specific probe (data summarized in Fig. 3). 
For the purpose of 'chromosome walking', a 
unique 5'-specific (pA079) and З'-specific (pA073) 
probe was prepared from clone ALLW-1283-C121 
and used in further screening of the human cosmid 
library. Two positive clones, designated MBIO and 
MB25, were found (Fig. 2A, lanes 2 and 3. and 
Fig. 2B, lanes 2 and 3), both extending in a 
direction upstream of clone ALLW-1283-CI21 
(Fig. 3). The inserts of these cosmid clones did not 
hybridize with v-sis (Fig. 2B, lanes 2 and 3). No 
positive cosmid clones were found after screening 
another 200000 colonies with pA073. 
In parallel experiments, two cosmid clones con­
taining c-sis sequences were obtained upon screen­
ing of the feline cosmid library (500000 colonies) 
with probes FAOl and FA02 (Fig. 2A, lanes 4 
and 5; Fig. 2B, lanes 4 and 5). The complete feline 
v-sis cellular homolog was present in these cosmid 
clones. Determination of the orientation of feline 
c-sis and construction of its restriction enzyme 
map was done in the same way as described for 
the human c-sis clones (Fig. 3). 
As summarized in Fig. 3, the three human 
cosmid clones contain overlapping sequences cor­
responding to a single contiguous region of human 
cellular DNA of about 65 kbp. The distribution of 
the \-sis homologous region is in accordance with 
previous reports [40-42] in which a total of six 
exons were identified. The feline DNA inserts 
represent about 60 kbp of contiguous cellular DNA 
and the organization of the v-s¿s homologous re-
gions seems similar to those in the human locus. 
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Fig. 3. Restriction endonudease map of the human and febne с-ш-containing DNA regions In the upper part of the figure, cellular 
DNA inserts of the human cosmid clones ALLW-1283-C121, MB10 and MB25 are shown Directly below these inserts, solid bars 
indicate the distribution of highly repetitive DNA sequences detected in the human c-sis region The next solid une represents a 
schematic restriction endonudease map of the human c-sis containing DNA region In this map, v-sis homologous genetic sequences 
are indicated as heavy bars. Homology with either half of the v-ju regions is indicated. Open boxes represent the DNA inserts of 
pAO70, pA079 and pA0121, which were used as molecular probes The DNA insert of pA073 contains the 3' -ял homologous 
region and, therefore, is depicted as a heavy bar The next line represents the SSV provira] genome The open boxes are the long 
terminal repeats (LTRs) The 5' and Э' halves of the viral oncogene ( -ш) were subcloned in bacteriophage ml3mp8 resulting in 
FAOl and FA02, respectively. The restriction endonudease map of the feline с-ш proto-oncogene is shown under the SSV genome. 
Again, the genetic sequences homologous to \-sis are given as heavy bars Their hybridization with the DNA inserts of FAOl and 
FA02 is specified. Febne DNA fragments containing genetic sequences homologous to the human DNA inserts of pAO70 and 
pA0121 are indicated as open boxes. The sohd bars below the feline reslnclion endonudease map represent highly repetitive DNA 
sequences within the febne c-sis region. The two solid lines at the bottom of the figure indicate the size and the relative position of the 
feline cellular DNA inserts within cosmid clones MB65 and MB70. B, BumHI, E, £coRI, H, //indili, К, Kpnl, Xb, Xbal, Xh, 
Xhol. 
Comparative analysis of the human and feline c-sis 
locus 
As an approach to identify c-si's-specific coding 
sequences outside the v-sis homologous regions, a 
comparative analysis of the cosmid clones ob­
tained from the human and feline gene libraries 
was performed. First of all, highly repetitive genetic 
sequences were identified. This mapping was per­
formed by Southern blot analysis using a number 
of restriction endonucleases and with 32P-labeled 
total human or feline DNA as a molecular probe 
(data not shown). The position of the repetitive 
sequences within the human and feline c-sts-con-
taining DNA region was determined and the re­
sults are summarized in Fig. 3. As can be seen, 
relatively long stretches of nonrepetitive DNA are 
present upstream of the v-sis homologous regions 
of both species. To see whether both species share 
homologous genetic sequences in this area, a num­
ber of restnetion enzyme digests of the human 
c-sis cosmid clone were hybridized with 32P-labeled 
feline c-sis containing cosmid clones (data not 
shown). The results indicated that there were ho­
mologous genetic sequences in addition to the v-sis 
related sequences. These sequences were found in 
an EcoKl/HindlU DNA fragment of 2.0 kbp 
(pA0121) and a Kpnl/Kpnl DNA fragment of 
3.8 kbp (pAO70), subcloned and used as probes in 
further studies (see Fig. 3). Southern blot analysis 
of human and feline genomic DNA with these 
probes indicated that they both represented unique 
DNA sequences (data not shown). Hybridization 
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analysis of the feline c-sis locus with probe pA0121 
revealed a 3.5 kbp Hindlll/Xhol hybridizing DNA 
fragment (Fig. 4A, lane 1). Upon digestion with 
restriction endonucleases Bamiil, Hindlll and 
Л іоІ a 2.0 kbp and an 1.5 kbp hybridizing frag­
ment were seen (Fig. 4A, lane 2). Hybridization of 
the feline c-sis clones with pAO70 yielded another 
HmdlU/Xhol restriction fragment of 3.5 kbp (Fig. 
4B, lane 1). Upon digestion of the feline cosmid 
clones with restriction endonucleases Bamiil, 













Fig. 4. Identification of unique genetic sequences in feline 
cosmid clone MB70 that are homologous to the human DNA 
inserts of pAO70 and рАОШ MB70 DNA (01 ng) was 
digested with restriction endonucleases Hindlll and ATioI (A, 
lane 1; B, lane 1) or with BamHI, Hindlll and Xhol (A, lane 
2; B, lane 2), electrophoresed through an 0.6% agarose gel, 
blotted onto nitrocellulose and hybridized to the 32P-labeled 
2.0 kbp £coRI/№ndIII insert of рАОШ (A) or 3 8 kbp 
Kpnl/Kpnl DNA insert of pAO70 (B). Molecular weight 
markers include λ DNA digested with restriction endonuclease 
Hindlll and DNA of φΧ174 digested with Haelll. 
hybridizing DNA fragment were detected (Fig. 4B, 
lane 2) (for localization of the DNA fragments, see 
Fig. 3). In Fig. 3, the identified homologous re­
gions in the human and feline c-sis clones have 
been depicted. These results indicate the presence 
of unique and conserved genetic sequences in close 
proximity and upstream of the \-sis homologous 
region in the c-sis proto-oncogenes of both species. 
Northern blot analysis of human c-sis transcripts 
The possibility that the additional homologous 
genetic sequences identified in the comparative 
analysis described above could represent a coding 
portion of the c-sis locus was tested in Northern 
blot analysis. Using a \-sis- (FAOl and FA02) 
and c-m-specific (pA073) probe, poly(A) selected 
RNA isolated from human lung tumor cells (lung 
carcinoma No. 4923) was shown to contain c-sis 
transcripts (Fig. 5, lanes 3, 4 and 5). No such 
transcripts could be detected in a similar analysis 
of RNA isolated from human cell line IARC-EW1 
[43] (Fig. 5, lanes 1 and 2). With probe pA0121, 
the same 4.2 kb transcript as detected with the 
\-sis- and c-iM-specific probes appeared to hy­
bridize (Fig. 5, lane 6). These results strongly favor 
the possibility that some genetic sequences in the 
1 2 3 4 5 6 
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Fig. 5. Northern blot analysis of RNA transcripts in human 
lung tumor cells. Poly(A)-selected RNA samples were obtained 
from a human cell line (IARC-EW1) (lanes 1 and 2) and a 
human lung tumor (lung carcinoma No. 4923) (lanes 3. 4. 5 and 
6) and screened (45-¿ig aliquots) in Northern blot analysis with 
the following sis probes: FAOl (lanes 1 and 3), FA02 (lanes 2 
and 4). pA073 (lane 5) and pA012l (lane 6). Molecular weight 
markers included 28 S and 17 S nbosomal RNA 
no 
2 0 kbp £coRI/#mdIII DNA fragment represent 
human c-sis coding sequences 
Discussion 
In the present study, the \-sis homologous DNA 
sequences of human and cat have been studied by 
Southern blot analysis followed by molecular clon-
ing of both sis cellular homologs Southern blot 
analysis revealed that the \-sis homologous region 
in both species was rather extensive Furthermore, 
a i/mdlll-RFLP was frequently detected in the 
human locus Among human DNA samples from 
ten unrelated individuals, including five leukemic 
patients, six appeared to have an additional 
Hmdlll site m one allele The other four were 
homozygous for the absence of this site Interest-
ingly, no individual was found to possess the 
Hmdlll site m both alleles The additional 
ЯшгіІІІІ site could be localized in the middle of 
the v-sis homologous DNA region 
With the v-sis viral oncogene as a molecular 
probe, the c-sis containing DNA regions were 
isolated from cosmid gene libraries of the two 
species A contiguous human DNA region of about 
65 kbp was isolated and it appeared to contain all 
the human v-sts homologous sequences distnbuted 
discontinuously over a DNA region of approx 12 
kbp The restriction endonuclease digestion data 
obtained in this study confirm data reported by 
Jotmsson et al [41], Chiù et al [42] and Josephs et 
al [44,45] In these studies, the size and distribu-
tion of the six human v-sis homologous regions 
are described in detail At the 3' end, the presence 
of ал untranslated region was reported and part of 
it appeared to lack homology with v-sts [45] This 
particular region is also present in cosmid clone 
ALLW-1283-0121 
The complete feline c-sis cellular homolog was 
represented in the inserts of cosmid clones MB65 
and MB70 The feline v-sis homologous sequences 
were dispersed over approx 12 kbp of the 60 kbp 
contiguous feline DNA region isolated Upon 
comparative hybridization analysis of the human 
c-sis cosmid clone ALLW-1283-C121 and the two 
feline clones, the existence of common and highly 
conserved genetic sequences m addition to the 
v-sis homologous regions became apparent 
Northern blot analysis established that a transcript 
of the c-sis proto-oncogene of man contained one 
of these sequences These results indicate that the 
sis proto-oncogene contains as yet unidentified 
coding sequences that map upstream of the region 
that was captured in the viral oncogene of SSV 
Indications for the concept that the c-sis locus 
contains additional coding sequences and that SSV 
acquired only a portion of this gene could also be 
deduced from the size difference of human c-sis 
transcripts [26,27] and the v-sis oncogene [23,24] 
DNA sequence analysis of the v-sis homologous 
DNA region in the human locus revealed that the 
first exon lacked an initiation codon, again indi­
cating the presence of additional exon sequences 
at the 5' end of c-sis 
A cDNA clone, designated pSM-1, was de­
scribed by others [46] This clone was obtained 
from mRNA isolated from HUT-102 cells and 
represented a truncated form of the c-sis mRNA 
About 2 7 kbp of 3' c-sis coding sequences ap­
peared to be present in pSM-1 and an initiation 
codon was found about 64 bp upstream of the 
v-sis homologous region Transfection of pSM-1 
into NIH-3T3 cells resulted in morphological 
transformation, while genomic DNA isolated from 
HUT-102 cells failed to do the same These authors 
speculated that the upstream c-sis genetic se­
quences might code for regulatory domains of 
PDGF, the putative gene product of the c-sis gene 
The newly discovered c-sis exon described m this 
report might be instrumental in verifying their 
speculation 
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ABSTRACT 
Comparative analysis of cosmid clones containing the human and feline o-
sis genetic regions revealed the similar structural organization of these 
areas in the two species. The areas shared seven different genetic regions 
in and around the с-зіз locus and one of these was related to -зіз. Another 
region, 1.9 kbp in size and located about 8 kbp upstream of the -зіз homo­
logous region in the human genome, also hybridized to the main с-зіз tran­
scriptional product of 3.5 kb. Comparison with a recently described с-зіз 
cDNA clone (Collins et al.. Nature 316, 748-750 (1985)) revealed that the 
1.9 kbp DNA region contained a large 5' c-sls exon of at least 1050 bp. In 
this exon, the presumed initiation site of the predicted PDCF-2 containing 
precursor protein was located and appeared to be preceded by a large un­
translated region. In the region Immediately upstream of this exon, a TATA 
box and a consensus sequence for a potential Spi binding site were found at 
similar positions in both species. This region also exhibited promoter ac­
tivity when tested in an assay in which coding sequences of bacterial 
chloramphenicol acetyltransferase (CAT; acetyl-CoA: chloramphenicol 3-0-
acetyltransferase, EC 2.3.1.28) were placed under its control. The five 
other DNA regions were found upstream and downstream of the human с-зіз 
transcription unit and also in an intron. Four of them contained repetitive 
sequences. 
Hybridization analysis of human and feline c-sls containing cosmid clones 
with a mixed synthetic nucleotide probe, which corresponded to sequences en­
coding amino acid residues 2-7 of chain 1 of platelet-derived growth factor 
(PDGF-1), suggested that the c-sls cosmid clones did not include PDGF-1-
specific genetic sequences. 
INTRODUCTION 
The human c-sls proto-oncogene contains coding sequences for a precursor 
protein, part of which is similar if not identical to chain 2 of platelet-
derived growth factor (PDGF-2) (1,2). The initial link between PDGF-2 and 
sis was provided by partial amino acid sequence analysis of PDGF and nucleo­
tide sequence analysis of the v-sls oncogene of simian sarcoma virus (3-5). 
Genetic sequences encoding PDGF-1 remain to be identified. Expression of 
с-зіз 1з found in endothelial cells (6-8), human placenta (9), mouse embryo 
tissue (10), human lung tumors (11) and a number of tumor cell lines (12). 
© IRL Press Limited, Oxford, England. 
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As the main transcriptional product, a mRNA species of about 3.5 kb 
(6,8,11,12), with coding potential for a protein of about 27 kd, was 
described (8,13). The precise function of the predicted c-sls encoded pro­
tein remains to be defined but it probably exhibits mitogen activity since 
It resembles PDOF with respect to amino acid sequence and also antigen and 
receptor binding characteristics (1,2,11-16). The responsiveness of fibrob­
lasts, mesenchymal cells and glial cell lines to the mitogen PDOF and also 
the stimulation by PDGF of DNA synthesis during wound healing is well esta­
blished (17-19). 
It was recently reported that expression of the c-sls gene is modulated 
during endothelial cell differentiation in vitro (7). Furthermore, it was 
shown in transfectlon experiments, that expression in mouse embryo fibrob­
lasts of human cDNA and genomic DNA constructs of c-sls resulted In a simi­
lar cell transformation (20,21) as observed upon transfectlon of the viral 
oncogene v-sls (22). Genetic sequences within or in close proximity of the 
locus may be involved in the control of such modulation of expression and 
they may also be relevant to the malignant potential of the locus. In an at­
tempt to Identify such regulatory sequences, we have compared the genetic 
organization of the с-зіз gene and its flanking sequences in two different 
species, man and cat. In this report, we present the identification and 
characterization of seven genetic regions that human and cat share in and 
around the c-sls transcription unit. 
MATERIALS AND METHODS 
Cosmld and plasmld clones, E.coll strains and cell lines: Isolation of the 
human and feline c-sls cosmld clones was described previously (11). pA068, 
pA070, pA073, pA0121, pA0151, pA0154 and pA0155 are subclones of the human 
c-sls locus (see also Fig. 2). pA070, pA073 and pA0121 were described else­
where (11). pA068 consists of a 3.8 kbp EcoRI/EcoRI DMA fragment subcloned 
In PSVBR91 . pA0154 and pA0155 consist, respectively, of a 1.3 kbp 
BamHI/EcoRI and a 4.3 kbp BamHI/XhoI restriction fragment subcloned In 
pUCl8. pA0151 consists of a 1.4 kbp EcoRI/Hindlll restriction fragment sub­
cloned in pAT153. pAOIII is a recombinant of pUCl8 containing a 3.5 kbp 
Hindlll/Xhol restriction fragment of the feline c-sls clone MB65. pSV2 was 
described by Gorman et al. (23) and pSuperCAT, a derivative of pSV2, was 
obtained from Dr. B. Dekker, University of Leiden, The Netherlands. pAOl65 
and рАОІбб are recombinants of pSuperCAT containing an 0.1 kbp Pstl/PstI hu­
man DNA fragment that is located Immediately upstream of the 5' c-sls exon 
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sequences. The insert in рАОІбб has the same orientation relative to the 
chloramphenicol acetyltransferase (CAT) coding sequences as to the c-sls 
coding sequences in the human genomic DNA. The orientation of the insert in 
pA0165 is opposite to that in рАОІбб. For the DNA sequence analysis, the 
DNA fragments were inserted into the polylinker site of M13mp8-11 (24). 
E.coll strain HB101 was used as a host for the human and feline c-sls sub­
clones. The recombinant M13 bacteriophages were propagated in E.coll strain 
JM101. Cell lines used in this study included HeLa (American Type Culture 
Collection (ATCC) CCL 2), Vero (ATCC CCL 81), HUT 102 (12) and Neuro 2A 
(ATCC CCL 131). 
Preparation of DNA probes and hybridization: Preparation of DNA probes and 
their labeling by nick translation was carried out as described (25). The 
specific activity of the probes used in the hybridization studies was (2-
8 
5)χ10 cpm/pg. Agarose gel electrophoresis, Southern blotting and hybridiza­
tion analysis was performed as described (25). The mixed oligonucleotide 
probe was synthesized as described (26) and the probe was labeled with Y-
32 
[ P]-ATP (3000 Cl/mmol) according to the procedure described by Maxam and 
8 
Gilbert (27) to a specific activity of about 2к10 cpm/pg. Hybridization 
о 
analysis with the mixed oligonucleotide probe was performed at 35 С for 16 
h in 6xSSC, SxDenhardt's solution, 100 pg/ml denatured salmon testis DNA and 
б 
2x10 cpm/ml labeled mixed probe. Following hybridization, filters were 
washed in 5 mM EDTA pH 8.0 and 6xSSC during one hour periods at 
о о о 
37 С, 40 С, and 45 С, successively, and dried. Autoradiography was per­
formed by exposure to XAR-2 film (Kodak) with Dupont lightning plus intensi­
fying screens. 
DNA sequence analysis: Sequencing of DNA fragments was according to the di-
deoxy method of Sanger et al. (28). The gels readings were recorded, edited 
and compared using the Staden programs (29). 
RNA isolation, Northern blotting and hybridization: Total cellular RNA was 
isolated using the lithium-urea procedure described by Auffray and Rougeon 
(30). Ten pg of mRNA, purified by oligo(dT)-cellulo3e affinity chromatogra­
phy, was glyoxalated, fractionated on 1.0 % agarose gels (31) and 
transferred to Hybond-N (Amersham). Hybridization of the Northern blots was 
carried out as described by Church and Gilbert (32). 
Assay for chloramphenicol acetyl transferase activity: The assay for 
chloramphenicol acetyltransferase (CAT) activity was performed as described 
by Gorman et al. (23). 
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Fig. 1. Identification of common genetic sequences in the inserts of the hu­
man and feline c-sis cosmid clones. MB65 (lanes 1, 2 and 3) and MB70 (lanes 
4, 5 and 6) were digested with restriction endonucleases EcoRI and Kpnl 
(lane 1), BamHI and Xbal (lane 2), Hindlll and BamHl (lane 3), Hindlll, 
BamHI and Xhol (lanes 4 and 5) and EcoRI and Xbal (lane 6). As molecular 
probes, the Inserts of the following human c-sis subclones were used: pAOl55 
(lane 1), pA0151 (lane 2), pAOl54 (lane 3), pAOl21 (lane 4), pA070 (lane 5) 
and pA068 (lane 6). Molecular weight markers include λ DNA digested with 
restriction endonuclease Hindlll and DNA of ФХ17Ч digested with Haelll. 
RESULTS 
Identification and characterization of seven genetic regions shared by 
the human and feline c-sis loci. 
As an initial approach to identify potential regulatory regions within or 
in close proximity of the c-sis locus, we compared previously described hu­
man and feline c-sis containing cosmid clones (11) by Southern blot 
analysis. We reasoned that genetic regions which modulated expression of c-
sis and which might be relevant to the malignant potential of the locus were 
likely to be conserved during evolution. A number of DNA fragments could 
32 
Indeed be identified when P-labeled feline c-sis cosmid clones were hybri­
dized with the human c-sis containing clones (data not shown). Following 
molecular cloning of 11 DNA fragments from the human c-sls containing cosmid 
clones and using them as probes, seven different genetic regions which were 
shared by man and cat could be identified (Fig. 1). One of these regions 
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Flg. 2. Homologous regions in and around the human and feline c-sls locus. 
In the upper part of the figure, the size and relative positions of the DNA 
inserts of three human cosmld clones ULLW-1283-C121 , MB10 and MB25) are 
shown. Directly below these Inserts, a schematic restriction endonuclease 
map of the human c-sls containing DNA region is presented. At the bottom of 
the figure, the size and relative positions of the cellular DNA inserts of 
two feline cosmid clones (MB65 and MB70) are given. Immediately above them, 
a schematic restriction endonuclease map of the feline c-sls containing DNA 
region is presented. Between the two restriction maps, the seven regions 
that man and cat share in this area are depicted as shaded boxes. Boxes of 
corresponding regions are shaded similarly and overlapping regions are shad­
ed accordingly. The human regions are numbered (1-7). Human region 6, which 
represents the v-sis homologous region, is subdivided in four v-sls homolo­
gous fragments which all belong to region 6. The positions of the DNA in­
serts of recombinant plasmlds are indicated by the names of the plasmlds 
above the shaded boxes. 
B, BamHIi E, EcoRI; H, Hlndlll; K, Kpnl; Xb, Xbal; Xh, Xhol. (For a detailed 
restriction endonuclease map see Ref. 11). 
(region 6) was homologous to v-sls (see also ref. 11) and a unique 
c-sis-speclfic probe (pA073) was prepared from the 3' part of this region. 
In Fig. 2, the localization of the seven DNA regions within the human and 
feline c-sls containing genetic area is depicted. 
To define these seven regions in and around the c-sls locus of the two 
species In more detail, we have further analyzed the molecular cloned human 
DNA fragments. It appeared from Southern blot analysis that region 1, 2, 3, 
6 and 7 contained repetitive sequences (data not shown). The presence of 
Alu-repeats in region 6 (33) was confirmed. In region 1, 2, 3 and 7, no hy­
bridization was observed when total human' DNA was used as a probe. The re­
petitive sequences In these regions, therefore, do not belong to the 
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Fig, 3. Identification of c-sis transcripts in a number of cell lines. 
Poly(A)-selected RNA was isolated from HeLa (lanes 1 and 2), Vero (lane 3), 
HUT 102 (lane 1) and Neuro 2A (lane 5) cells and screened (10 pg aliquote) 
in Northern blot analysis with the inserts of pAOl21 (lane 1), pA073 (lanes 
2, 3. 1 and 5) as molecular probes. Molecular weight markers include \ DNA 
digested with the restriction endonuclease Hindlll. 
category of highly repetitive sequences (data not shown). Region 1 contained 
only unique genetic sequences. In Northern blot analysis of poly(A)-seleoted 
RNA isolated from HeLa cells, a 3.5 kb transcript was observed using pA073 
(c-sis-speclfic) or pA0121 (containing region H as insert) аз molecular 
probes (Fig. 3, lanes 1 and 2). Transcripts of similar size were also 
detected with these probes in a HTLV-I infected human Τ cell line (HUT102) 
(Fig. 3, lane 4) and the Vero cell line (Fig. 3, lane 3). The c-sis-related 
transcript in murine neuroblastoma cells was slightly larger (3Ό (Fig. 3, 
lane 5). Region 5 also contained only unique DNA sequences but it did not 
hybridize to the 3.5 kb c-sis transcript (data not shown). 
DNA sequence analysis of human region 4 and its feline counterpart. 
To resolve the question to what extent the genetic sequences in the 
unique human region 4 and the corresponding region in the cat genome were 
homologous, we have performed DNA sequence analysis. The complete nucleotide 
sequence of human region 4 and most of its feline counterpart were compared 
(Fig. 4). A remarkable homology between the human and feline DNA could be 
observed. Nucleotides printed in capitals represent sequences also found in 
a recently published cDNA clone of human c-sis expressed in endothelial 
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cells (8) and they can therefore be considered as exon sequences. As can be 
seen In Fig. Ί, a continuous stretch of at least 1050 nucleotides constitute 
a single new exon. Homology between man and cat in this exon was 90 І. To­
gether with the six already established c-sls exons (13) this new exon could 
form a mRNA transcript of about 3.5 kb, a size similar to that of the main 
c-sls transcript observed in a number of human cells (6,8,11,12) (see also 
Fig. 3). At its 3' end, a consensus splice Junction was found. The 5' end of 
the exon remains to be defined. Within the human and feline exon sequences, 
four initiation codons were present. Three of them did not seem to be func­
tional since they were followed almost Immediately by a stop codon. The 
fourth ATG codon, which was found 63 nucleotides upstream of the 3' splice 
Junction, is in-phase with the PDGF-2 open reading frame in the following 
exons (8,13). The 63 bp coding region of the new exon contained genetic se­
quences for a hydrophobic amino terminal sequence of the predicted precursor 
protein of PDGF-2. 
Within the 5' portion of the human exon, a triplet of repeats (GCAGCTC) 
was followed by a doublet of a similar repeat (GCAGCCC). Interestingly, one 
of the repeats of the triplet was deleted in the c-sls cDNA clone published 
by Collins et al. (8). Five other differences, all point mutations, between 
human region Ί and this c-sis cDNA clone could be observed, namely two sin­
gle nucleotide substitutions (an A instead of a G at position 683 and a Τ 
instead of an С at position 1383), two deletions (position 580 and 1151) and 
one insertion (а С at position 1262) (Fig. 4). 
The exon sequences in human region 1 were preceded by a TATAAA sequence, 
the consensus promoter sequence for RNA transcription of eucaryotic genes 
(Fig. 4) (35). At the same position in the feline DNA, the same TATAAA se­
quence was found (Flg. H). The observation that the 3.5 kb c-sls transcripts 
observed in a number of cells have the same length as the combined overlap­
ping sequences in a number of recently published cDNA clones (8,13) is in 
support of the possibility that transcription of the c-sls locus starts in 
close proximity of this TATAAA containing region. In addition to the TATAAA 
consensus sequence, some other promoter-specific sequences were present 
upstream of the TATA box (see Discussion). 
To test this potential promoter region for promoter activity, the 0.1 kbp 
Pstl/PstI human DNA fragment, which contained the TATAAA box and the other 
promoter-specific sequences, was subcloned in pSuperCAT and the recombinant 
рАОІбб was transfected into HeLa cells. As negative controls, pSuperCAT It­
self or pAOl65 (pSuperCAT containing the 0.4 kbp Pstl/PstI DNA fragment in 
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Пила η c-a ls gaat tcaggctctcagact.Bcagagcct.gagt.ccc Lece tgccatgcetgtgecagggLggaaatglctggt.cctggaggggagcgt.geâctcctggccL 100 
Human с s i s tggcLctggagacatccccctagaccacgtgggctcctaacctgtccatggtcacigtgctgaggggcgggacggtgggtcacccctaglLcttttttcc 200 
tei Ine e s i s cigeagacgactcoccaaaecacgtgggctagaaatcaggccacggLcaoLgLgotaaggggcggggcgctcagLcgcccctagtLetceciteg 95 
Psti 
human c - s l s ccagggccagattcatggactgaagggLtgctcggctcteagagaccccctaagcgccccgccctggccccaagccetcccccagctgecgcgtcccccc 300 
ret ine с s i s ccagggccgggctcccggag- gggctgcggagctctcagagace-cctgagcgccccgcccccgcctcaggccctcccggagctccc cccect 186 
hu-nan с a l s cetcctggcgetgactccgggccegaagaggaaaggctgtctccacccacctctegcactctcccttctcctt tataaajgccggaacagctgaaagggl ΊΟΟ 
r ι ι r I 1 1 ι 
Teline с s i s cttcccggtgctgactctcggccagaagaggaaaggcagtccccacccacctctagcactctcccttctcctt lataaajgccggaacagctgaaagggt 286 
human c - s l s ggccacttctcctcetgcagccgggagc gCCTGCCTtKL-TCCCTGCOCACOCXAQCCTCCCCCOCTGCCTCCCT-AGOOCTCCCCTCCOCCCOCCiGC 196 
Tel ine c - s l s ggcaacUctectcctgccgccgggagcagCCCGCCTCTCTGCCCGCOC(£eCGCAGCCTCCCCCQCTGC^^ 386 
human c - s l s ГСССДТТ!ТТСАГІСССТДШТЯОЛС1ТЛ(ЛТтаЗДГСАС1САедте Ъ9В 
f e l i n e с s i s GCœâTCTTTCATTTCCCAGATTGCOiTlTTTTGCGCACACACiXATACACACACm ΊβΊ 
human С s i s TGCAAAGAttAAACCGGAttAOCCgCAGCTCG»OCTCGCAaCTO 6 9 8 
f e l i n e C - a l s TQCAAJUUCAAC-CCCCAKAOCCGCAOCTCACAflCC CAOAOGACOCCCACAGCGOC-AGCOCCCACACACACGOAC 5Ъ9 
· _ _ „ 
ι t ι ι 
f e l i n e c - s l s CCACOUCTC-CGCCGCCTCCAOCnnCTGCCCCGCCCGGCACT(£OCWiCGaOCACfnC^ 6 5 5 
h u n a n c - s l s СТССаССОСДАСАСОСТТХСаХСОХТ-АСІЖОССССаиХСИЖАСГГТОСАССТСПДХіиХС^ 97 
f e l i n e c - a l s - ДААООСЮАСАСОСТССООССессаХІССССШХОСОСОССАС^^ 7 5 3 
human c - a l s ОСАААААЫ11 И 1Ц0ОО0ДСАСТТ«асСТПаСИГГаЖСАОСТССД0СТТТСССАГГТТСОиЦЦ:С ГnUCAGAAAATCTTOCAUAAAQCTAAOCC 9 9 7 
f e l i n e c - s l s ОСАААААСГ ГГГ TOUOOOGAGAi: Ι Г lOUtCl ІЦаСТОССССОСТСТДАСТТТСССАСТТСОСОООССТТТСТАСААААТСГГОСААААААОСТААОСС 8 5 3 
human c - s l s ООСОСССАСАСДАМАСОССТСГАОСССОССАСТСААаАССААССДТССАСТОСССТСГПХП Г IUI 111 IИДАДТТОСАСТССССТОСОСОСССССА 1 0 9 7 
f e l i n e c - s l s AOCOreAGAOCiAAACOCCTATAOCCOrewrTGUQACGAACCATCttiCTO«^ 9 5 3 
human с - з і з CAC<UCTAGA£CCCTCGGCTGCTTCGCWœAGCCCCCCGGCCGT(^^ 1197 
r ι ι t t i i 1 
human C - s l s GAOCOCCTCATCGCCGCCGACCCCIGCCGIGCCCA«: - CCCCTCCCCAOCCOCCCACCCTCaCCGCGGGCGCaXGCKTCCATCTACGCCTCCG 1 3 8 6 
f e l i n e с - з і э гшжяххггсАттхжАалсжаі(хгсісгжлпіііг.ііііт^аегс.іт^ i25i 
m n r c w a l f l s l c c y l r l T s a e 
hunan c-sis оасссссхіхюоссооосссаадотссхЕдтштсастастооасастсттсгпігст^ іч б 
'el ine c-sls 0ООСССС0С0000СС0(ЮССС0ОА<ПССДАТОААТТОСТОСТСООСОСТСТТССТСТСТСТСТОСТтТАС^^ gagtt 1351 
human c-sls gccacggcggcteeg8ctee*tc""ttcattcaitaccttcgcccccaccttctgaccgccccctcct"tccctgcagtaaactttggacecttgcagcc 1584 
1 r 1 1 ι ι ι 1 1 1 
feline c-sls gcgacggcggcgggggctggttogcttcatccattacgcccaccctcaccccctggccgccccctcccctccctgcaggggactttggaccctcgcagcc 1151 
human c-sls cgcgagoctgacgccgggcgctgggtgacctcttcgggctggga-gcgaggtccggg-ggtgacaggctctaagggaaggeaacagcggtggcttlctlt 1682 
feline c-sls cacgggcctagcgccgggcgctaggtgacctccgagggctgggacgcgaggtgcgggaggtgccaggctctgaggggagggggcgggggtggcttgcttt 1551 
hunan c-sls ccaaccggcgggcgaatctggctccctaagccgttccgtgtcgegagaegatgtgtgtgeccctgtcccccaccctttgggaacccgagaacaagcccct 17 2 
1 1 1 1 it 11 
feline c-sls eccat gggcgatcccagatcaccggcccttttageetcgggggagegtgtgtetggccctgtcccccacccetcaggaacctgaa 1636 
human c-sls tcccggccgggggagagggggtgggg-tggtgcccagggtgcagaaggcagcgcgtectccçgagcccactlcggcgccagcctcggcttaggctctgtc 1Э8? 
feline c-sls — - gggagagagagtgggggtggtgccgagggtgcagaggccagcgcgttctcccgagcccacttcggttccagcct aggttccgtc 1721 
HlndlII 
fumar c-sls ctgccatcggcttgcccaggaggtgcaagctt 7913 
feline с sis caggacccggcttgcacgggaggtgcgagctc 1752 
Sacl 
Flg. Ц, Comparison of the nucleotide sequence of human s i s region U with se­
quences of i t s fel ine counterpart. Exon sequences, based on sequence data of 
the s i s cDNA clone isolated by Collins et a l . (8) , are printed In c a p i t a l s . 
The f i r s t three ATG codons are underlined and as ter i sks (*) mark termination 
codons that are in-phase with a preceding ATG. The amino acid sequence of 
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the 63 bp open reading frame Is given In the conventional one letter code. 
The putative TATA boxes of the human and feline locus are placed In a box. A 
closed circle (·) and an open square (D) mark the 5' ends of, reèpectlvely, 
the human genomic с-зіз subclone Isolated by Gazlt et al. (21) and the cDNA 
clone described by Ratner et al. (13). Two sets of small repetitive se­
quences are Indicated with arrows ( -, * - ) . The consensus sequence for 
the potential Sp1 binding sites and the CCGCCC sequence similar to the one 
found In the SVIO early promoter region are underlined. 
an orientation opposite to that in рАОІбб) was used. As a positive control, 
pSV2 was Included In the experiments (23). Measurements of CAT activity in 
HeLa extracts were made Ίβ hr after Introduction of the DNA Into the HeLa 
cells. Analysis of thin layer chromatograms revealed that there was a con-* 
slderable amount of CAT enzymatic activity in extracts of HeLa cells 
transfected with рАОІбб. No such activity was detected in extracts from 
cells transfected with pSuperCAT or рА01б5. These results Indicated that 
the 0.4 kbp Pstl/PstI human DNA fragment had the capacity to function аз a 
promoter. 
Analysis of the human and feline c-sls containing cosmld clones for the 
presence of PDGF-1 related sequences. 
The observation that a number of DNA regions In and around the human and 
feline c-sls coding region, which encodes a protein similar if not Identical 
to PDCF-2, appeared to be conserved, raised the possibility of the presence 
of genetic sequences related to those encoding PDGF-1. To test this possi-
billty, we prepared a mixed synthetic oligonucleotide probe based upon the 
amlno-terminal amino acid sequences (residues 2-7) (3,4.36) of PDGF-1. The 
composition of the synthetic probe is depicted In Fig. 5A. Hybridization 
analysis was positive in the case of a 5.0 kbp Hindlll/Hlndlll DNA fragment 
of cosmld clone ALLW-1283-C121 (Fig. 5B, lane 3). None of the other human 
(Fig. 5B, lanes 1 and 2) or feline (data not shown) cosmld clones hybridized 
to the mixed synthetic probe. Upon cloning and further analysis of the 5.0 
kbp Hindlll/Hlndlll DNA fragment, the matching sequences were localized in a 
1.0 kbp Sau3A/HlndIII DNA fragment (Fig. 5C). Nucleotide sequence analysis 
of this fragment revealed a match of 15 out of 17 nucleotides of one of the 
probes In the mixture (Fig. 5D). However, this sequence appeared to be no 
part of a region encoding the amlno-termlnal portion of PDGF-1. 
DISCUSSION 
In this report, we describe the structure and the nucleotide sequence of 
the 5' region of the human and feline c-sis proto-oncogenes and provide the 
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ЗаиЗА Н р а І І 
GATCTTGGGACAGCTTCTTCAGCCTGCCAGGCCTCCTTTCCCATCTCTGAAGTGAGCTGTCCACCTGGAGCCCTGCGGAACCTGTGCCCAGGAAAACCAGGCTCCGC 
Τ Τ Τ 
CGHACHGC TC TCAAT 
C G C 
F i g . 5. I d e n t i f i c a t i o n of g e n e t i c sequences homologous t o t h e s y n t h e t i c 
mixed p r o b e . (A) Composition of the mixed p r o b e . The N-terminal 15 amino 
a c i d s of PDGF-2 and 9 amino a c i d s of PDGF-1 a r e a l i g n e d for maximum homology 
( 3 , 3 6 ) . The composi t ion of t h e mixed probe i s i n d i c a t e d under t h e amino a c i d 
sequence d a t a . (B) Southern b l o t a n a l y s i s of human c - s i s cosmid c l o n e s with 
t h e mixed p r o b e . Clones MB10 ( l a n e 1 ) , MB25 ( l a n e 2) and ALLW-1283-C121 
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(lane 3) were digested with the restriction endonuclease Hlndlll. Hybridiza-
tion of the Southern blots was as described under Materials and Methods. (C) 
Restriction endonuclease map of the human c-sls cosmld clone ALLW-1283-C121. 
The upper heavy bars represent highly repetitive DNA sequences. The next 
line represents a schematic restriction endonuclease map of the human c-sls 
locus. At the bottom of the figure, black boxes Indicate the relative posi-
tions of v-sls homologous sequences and the open box the DNA region that hy-
bridized with the mixed synthetic probe. 
B, BamHIj E, EcoRI; H, Hlndlll; K, Kpnl; S, Sau3A; Xb, Xbal¡ Xh, Xhol. (D) 
Nucleotide sequence of the first 107 bp of the Sau3A/HlndIII DNA fragment 
Illustrating the homology with the mixed synthetic probe. 
first characteristics of their promoter regions. Comparative analysis of the 
human and feline c-sls containing DNA areas resulted In the identification 
of seven DNA regions which the two species have in common. These regions are 
highly homologous In the two species and their genetic organizations are 
colinear. One of the regions, region 6, constitutes the human and feline 
v-sls cellular homolog which we have described before (11). In region 4, the 
5' region of the transcription unit of the c-sls proto-oncogene la located. 
We conclude this from the following observations. Combination of the over-
lapping inserts of the human sis cDNA clones (8,13) constitutes a stretch of 
DNA of about 3.5 kbp which resembles the size of the c-sls mRNA species 
detectable in a number of cell lines. This means that the large exon 
described in this paper contains almost all the 5' genetic sequences of the 
messenger although the precise position of the cap site remains to be Iden-
tified. Further support for our conclusion is based upon the fact that a 
TATA box is present in the DNA region immediately upstream of the large 
exon. Furthermore, this region exhibited promoter activity in an assay for 
transcriptional activity. The TATAAA consensus promoter sequence for RNA 
transcription of eukaryotlc genes is present at the same positions In the 
c-sis loci of the two species. Since the distance in many eukaryotlc genes 
between the TATA box and the cap site of the mRNA Is about 30 nucleotides, 
it can be concluded that from the 5' sis cDNA clone described by Collins 
et al. (8) only a few nucleotides of the 5' region of the mRNA are exclud-
ed. In both species, additional promoter-specific consensus sequences are 
found upstream of the TATA box. A (G+C)-rich region is located about 80 nu-
cleotides upstream of the putative RNA transcriptional starting region and 
the characteristic CCCCCC sequence (position 259-264 in Fig. 4) is present 
within this region. In the SV40 early promoter region, six copies of this 
sequence were found in a similar (G+C)-rich region (37) and in the myc 
proto-oncogene the hexanucleotlde Is located In close proximity to the TATA 
box (38). 
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At about 200 nucleotides upstream of the TATA box a GC box consensus se­
quence (GGGGCGGOAC In the human and GGGGCGGGGC in the feline DNA) for the 
binding site of the promoter-specific factor Sp1 (39) is present. A number 
of GC box-containing promoters have been described (39) and they include 
cellular as well as viral genes. However, it remains to be established 
whether the GC box in the sis locus is involved in Spi binding. 
A striking characteristic of the 5' с-зіз exon is its long noncoding re­
gion (at least 987 bp). The messenger of the insulin-like growth factor II 
precursor has a similar long 5' untranslated region (40). It is possible 
that the long 5' untranslated region of the c-sls locus plays a regulatory 
role but this needs further studies. The presence of four ATG initiation co-
dons was also remarkable. Most likely, translation starts at the fourth Ini­
tiation site (position ΙΊΙΤ). This ATG codon meets the criteria postulated 
by Kozak (41,12) and it also is the beginning of an open reading frame of 
723 bp (8,13) that encodes the predicted PDGF-2 precursor protein of about 
27 kd. 
The other five genetic regions which man and cat have in common in and 
around the c-sls transcription unit are not yet fully characterized. It is 
clear from our data that at least one of these regions lies in an intron and 
that its sequences are more conserved than other intron regions. This intron 
region Is not present in the main c-sls transcript (data not shown). Furth­
ermore, it is of Interest to note that some of these regions contain repeti­
tive DNA sequences. The presence of such repetitive sequences in the proxim­
ity of cellular coding sequences was reported before (43) and could have 
functional implications. 
A still unresolved Issue pertains to where the genetic sequences that en­
code the PDGF-1 chain are located. We have tested the possibility that they 
are present in the DNA areas described in this study. Southern blot analysis 
with a PDGF-1-speclflc synthetic mixed probe did not reveal any potential 
region. However, It should be noted that in the case that a splice site 
would be located In the sequences recognized by the mixed probe, a match 
could have escaped detection. Our results suggest that the PDGF-1 encoding 
sequences are located somewhere else, even on another chromosome. 
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ABSTRACT 
The structure and genetic organization of the transcription unit of the 
c-sis proto-oncogene was determined. Comparative nucleotide sequence 
analysis of the exon sequences of feline and human c-sis revealed a very 
high degree of homology. The cap site as well as the poly(A)-addltion site 
of the sis transcript of each species was identified and found in similar 
positions. An insert of 4 amino acids was found in the deduced translational 
product of feline c-sis and it was located at the amino-terminus of the re­
gion that constituted the platelet-derived growth factor domain. An insert 
of 149 bp present at the 5' end of exon 7 of human c-sls but absent in the 
simian sarcoma virus v-sis oncogene was also present in the feline c-sls 
proto-oncogene. 
INTRODUCTION 
Upon the demonstration that the function and the amino acid sequence of 
one chain of the human platelet-derived growth factor (PDCF) was nearly 
identical to the oncogene product of the simian sarcoma virus (SSV) (1,2,3)1 
studies on the cellular c-sls counterpart got great impetus. Sequences of 
the c-sis proto-oncogene appeared also to be acquired by another acutely 
transforming retrovirus, namely the Parodi-Irgens strain of feline sarcoma 
virus (PI-FeSV) (4). The c-sls-denved sequences in PI-FeSV and SSV are ex­
pressed in different contexts of the retroviral genomes. PI-FeSV encodes a 
76 kda gag-sis polyproteln (5) and SSV a 28 kda protein that contains a 
short NH -terminal leader sequence derived from the viral env gene (6,7). 
In both cases, constitutive expression of these PDGF-like mitogens seems ca­
pable of inducing neoplastic transformation (4,8). 
In previous studies, the structure and genetic organization of the human 
(9,10,11) and feline (12,13) c-sls proto-oncogenes were described. Using nu­
cleotide sequence analysis of genomic and cDNA clones, the distribution of 
the 7 human c-sis exons was obtained (14,15,16). In the region upstream of 
the first human sis exon, a "TATA" box and consensus sequences for a poten­
tial Spi binding site were found. At similar positions In the feline c-sls 
© IRL Press Limited, Oxford, England. 
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proto-oncogene, the same sequences were present. The upstream region exhi­
bited promoter-like activity when tested in an assay in which coding se­
quences for bacterial chloramphenicol-acetyl-transferase were placed under 
its control (13). Therefore, it possibly represents the promoter region of 
the c-зіз locus and controls the synthesis of the c-sls mRNA (13). Further 
evidence for this possibility could be obtained by precisely defining the 
sis transcript. In the present report, we provide such evidence. We present 
data from nuclease SI protection experiments and comparative nucleotide se­
quence analysis of sis cDNA clones and define the 5' and 3' boundaries of 
the feline and human sis transcripts. 
MATERIALS AND METHODS 
Biological materials: Cells were grown in Dulbecco's modification of Eagle's 
medium (DMEM) supplemented with 10Ï calf serum (GIBCO). Cell lines used in 
this study Included HeLa (American Type Culture Collection (ATCC) CCL 2), 
ML-1 (1?) and PC3 (ATCC CRL 1435). Feline placentas were obtained from the 
Central Animal Laboratory of the University of Nijmegen, Nijmegen. 
Recombinant DNA clones: Isolation of human and feline c-sls cosmid clones 
and pA073, a human c-sis specific subclone, was described previously (12). 
pHNI is a recombinant clone of Xgtll and a 0.6 kbp sis-speclfic cDNA isolat-
ed from an oligo(dT)-primed human cDNA library. A4U, a subclone of pA0121 
(12), consists of a 243 bp Alul/Alul DNA restriction fragment subcloned in 
МІЗтрІІ. A53 is a recombinant of MlЗтрі1 containing a 235 bp Alul/Alul DNA 
restriction fragment isolated from рАОІЧЧ (13). A 1.3 kbp BamHI/Hindlll DNA 
restriction fragment, which represents a З'-specific portion of c-sls, was 
isolated from MB70 (12) and subcloned In pUCl8 resulting in pPHSI. pAct is 
an actin-specific clone described by Dodemont et^  al. (18). E.coli strain 
HB101 was used for the propagation of plasmids and the recombinant MI3 bac­
teriophages were propagated in E.coli strain JM109. 
DNA sequence analysis: DNA fragments were ligated into the polylinker region 
of МІЗ mp8-11 (19). Sequencing of the DNA fragments was according to the dl-
deoxy method of Sanger et_ al. (20). Gel readings were recorded, edited and 
compared using the Staden programs (21). 
RNA isolation and hybridization: Total cellular RNA was isolated using the 
lithium-urea procedure described by Auffray and Rougeon (22). Ten pg of 
oligo(dT)-cellulose purified mRNA was glyoxalated, fractionated on 1ï 
agarose gels (23) and transferred to Hybond-N (Amersham). Isolation of DNA 
probes, their nick-translation and hybridization of Southern blots were car-
Nucleic Acids Research 
ried out as described before (24). Hybridization of Northern blots was per­
formed according to the method described by Church and Gilbert (25). 
Construction and screening of cDNA libraries: 01ιgo(dT)-primed cDNA li­
braries of ML-1 or feline placenta mRNA were constructed in Xgtll as 
described by Roebroek et^  al. (26). About 1.2x10 plaques obtained upon in­
fection of E.coli Y1090 (27), were screened as described by Hanahan and 
Meselson (28). 
Nuclease SI analysis: Nuclease SI mapping was carried out as described by 
Van Leen et al. (29). 01igo(dT)-selected mRNA (5 pg) from feline placenta or 
human PC3 cells were hybridized with the inserts of A53 and АЦЦ, respective­
ly. The inserts of A53 and AtU were labeled using the method of Sanger (20) 
and purified by electrophoresis in a 6Í polyacrylamide/7 M ureum gel. Hy-
bridizations were performed at 55 C. Nuclease SI (Boehringer) concentrations 
used in the experiments were 25 units/μΐ and incubations were performed at 
370C. 
RESULTS AND DISCUSSION 
Genetic organization of feline c-sis. 
In an approach to define the c-sis transcription unit, we decided not to 
limit our studies to the sis transcript of only the human species but to in­
clude also the feline sis transcript. We reasoned that by such an extension 
species-specific characteristics could be eliminated and a more general 
description of the c-sis transcription unit could be obtained. Detailed 
genomic information about the c-sis locus, however, was only available for 
human c-sis. To obtain the necessary genomic data about the feline c-sis 
locus, the genomic organization of the feline sis transcription unit was 
determined by comparative analysis of previously described cosmid clones 
(12,13). Overlapping inserts of these clones contained the complete feline 
or human c-sis proto-oncogene (12,13). Based upon the known exon distribu­
tion in human c-sis (15,16), the location of the feline c-sis exons was 
determined accurately by Southern blot analysis of the inserts of the feline 
cosmid clones using human DNA fragments containg c-sis exons as molecular 
probes (data not shown). In control experiments, DNA fragments identified 
as putative sis exons were tested for their ability to detect c-sis tran­
scripts in Northern blot analyses (data not shown). Upon identification of 
DNA fragments that contained the feline c-sis exons, the nucleotide sequence 
of them was determined. The topological distribution of the feline and hu­
man c-sis exons is given in Fig. 1 and reveals great similarity. In Fig. 2, 
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Topology of the feline and human c-sis exons. The bars in the upper and 
lower part of the figure reoresent schematic restriction endonuclease 
maps of the feline and human c-sis proto-oncogene, respectively. Open 
boxes represent the 5' and 3' noncoding exon sequences, while coding se­
quences are depicted as solid boxes. The positions of the used ATG (I) 
and TGA (t) codons are also shown. Between the restriction endonuclease 
maps, the nucleotide sequence of the 5' and43' ends of the feline and 
human sis transcription units as well as their flanking sequences are 
given. Exon sequences are depicted as capitals. 
nucleotide sequence data of the feline sis exons and a small portion of 
their flanking sequences are shown. It should be noted that results ob­
tained from nucleotide sequence analysis of feline sls-speclf1c cDNA clones 
that are described later in this report are already included in the figure. 
The position of the "TATA" consensus promoter sequence is also indicated in 
the figure. 
Expression of the feline c-sis proto-oncogene. 
To precisely define the exons in the sis transcription unit, analysis of 
cDNA clones prepared with sis mRNA was required. To select appropriate 
sources for sis mRNA, we analyzed poly(A)-selected RNA from a human prostate 
carcinoma (PC3) and a myelomonoblastoma (ML-1) cell line and from specimens 
of feline placenta (Fig. ЗА). Selection of feline placenta was based upon 
studies by Coustm et^  al. (30) who demonstrated the presence of relatively 
high levels of c-sis mRNA in placenta tissue. As a c-sls-specific molecular 
probe, pPHSI was used. In an attempt to compare similar amounts of poly(A)-
selected RNA, RNA concentrations were estimated based upon O.D?, readings 
and ethidium bromide staining. As an additional control experiment, levels 
of actin transcripts were estimated by Northern blot analysis (Fig. 3B). 
Northern blot analysis of mRNA isolated from feline term placentas (Fig. ЗА, 
lane 1 ) or from placentas containing embryos that were about 3 weeks old 
(Fig. ЗА, lane 2) revealed the presence of a 3.5 kb sis-specific transcript. 
However, a difference in the level of expression of sis seemed to exist in 
Nucleic Acids Research 
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2. Nucleotide sequence of the feline c-sis proto-oncogene. Lower case 
letters indicate nucleotides not belonging to the exon sequences of the 
feline c-sis proto-oncogene. The exon sequences are presented by capi­
tals. The "TATA" box sequences are placed m a box. A closed circle (·) 
and an open square (Q) mark respectively the cap site and poly(A)-
addition site determined by Rao et_ al. (16) in the human counterpart. 
The ATG codon preceeding the large open reading frame is underlined and 
an asterisk (¥) marks the used TGA stopcodon. 
the placenta specimens of the two stages of pregnancy. The amount of c-sis 
mRNA transcripts in term placenta was clearly higher than in the placenta 
with embryos of 3 weeks old. As can be seen in Fig. ЗА, the sis mRNA level 
in PC3 cells (lane 3) was somewhat higher than in ML-1 cells (lane 4). Com-









3. Northern blot analysis of RNA transcripts of feline placentas and human 
cell lines. (A) Poly(A)-selected RNA was isolated from feline term pla­
centas (lane 1), from placentas containing 3 weeks old embryos (lane 2), 
human PC3 (lane 3) or human ML-1 (lane Ό cells and screened with the 
inserts of pPHSI (lanes 1 and 2) and pA073 (lanes 3 and Ό as molecular 
probes. (B) Screening of the same Northern blot as in (A) with the in­
sert of pAct as molecular probe. Molecular weight markers include λ DNA 
digested with the restriction endonuclease Hindlll. 
parison of the size of the human and feline c-sis mRNAs revealed no major 
differences. A weak hybridization signal at about 2.6 kb was detected in RNA 
preparations from PC3 and ML-1 cells. The nature and origin of this tran­
script is not known at present but it was not seen in the feline placenta 
specimens. Slamon and Cline (31 ) have studied sis expression during em­
bryonic development of the mouse. Higher levels of sis mRNA were found at 
early stages of development than at later stages. However, it should be not­
ed that tissue specimens taken during the early stages of embryonic develop­
ment included embryonic as well as extra-embryonic tissue. This in contrast 
to specimens from later stages in development in which only embryos were 
studied. The observed differences in the levels of sis transcription is of 
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interest, especially in light of the report that mRNA levels of the PDGF-
receptor are higher in term placenta than in earlier stages of pregnancy 
(32). However, for a proper evaluation of the observations, identification 
of the cell types that express tne PDGF receptor and the sis product is re­
quired. 
Isolation of sis cDNA clones. 
Using poly(A)-selected mRNA from feline term placenta or human ML-1 
cells, a feline and human cDNA library was constructed in Agtll. Initial 
screening of the feline cDNA library (about 1x10 plaques) was performed 
with a combination of two different probes. These included a 3'~sis-specific 
probe (insert of pPHSI ) and a 5'-sls-specific probe (a 1.5 kbp BamHI/XhoI 
insert of рАОІЧЧ, which contained the 3'end of the first sis exon). Screen­
ing resulted in the identification of 16 positive cDNA clones. Of these, 15 
hybridized to the 3 '-sls-specific probe. Since the internal EcoRI restric­
tion endonuclease recognition sites within the cDNAs were not methylated 
during the construction of the cDNA libraries, the inserts of all 15 clones 
appeared to be located downstream of the internal EcoRI site in exon 3 of 
the feline c-sis proto-oncogene. Only 1 positive clone (FA0184) was isolated 
whose insert was located upstream of the internal EcoRI site. The nucleotide 
sequence of the cDNA insert of FAOlSI and of 6 cDNAs that were located down­
stream of the internal EcoRI recognition site was determined. The insert of 
FAOI8I4 starts at position 835 and stops at the EcoRI recognition site. The 
inserts of the 6 other cDNAs varied in lenght between 0.9 and 2.2 kbp. One 
cDNA contained a poly(A) tail and, based upon this observation, the 
poly(A)-addition site could be mapped at position 3355 (Fig. 2). The 3' ends 
of the other five cDNAs stopped at various positions (3301; 3301 ; 3327; 
3332; 3343) (data not shown). 
Screening of the human ML-1 cDNA library with the insert of pA073 as a 
molecular probe resulted In the isolation of pHNI. To map the poly(A)-
addltion site in the human sis transcript, the nucleotide sequence of the 
0.6 kbp insert of pHNI was determined (data not shown). This sequence ap­
peared to be identical to nucleotide sequences of cDNA clone pSM-1 described 
by Ratner et^  al. (15). The sequence of pSDI, a human sis-specific cDNA 
clone isolated by Rao et al. (16) lacked sequences at the 3' end. Comparis­
on of the nucleotide sequence data of our human and feline sis cDNA clones 
indicated that the DNA region in which the poly(A)-addition site was located 
was well conserved. Only two small deletions in poly(A)-stretches (4 adenine 
residues in human and 1 In feline; see Fig. 1) were observed. In both 
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species, the same nucleotide constituted the poly(A)-addition site and the 
same site was also found by Ratner et al. (15). The poly(A)-addition site 
proposed by Rao et al. (16) can be found 30 nucleotides upstrea-n of the site 
proposed in this paper (Fig. 1 and 2). No authentic polyadenylation signal 
(AATAAA) was observed in our isolates of the feline and human c-sis proto­
oncogene. Rao et^  al. (16) have described an AATAAA sequence 18 bp down­
stream of their poly(A)-addition site. In our feline and human cDNA clones, 
a "C" instead of a "T" was present in the sequence at that position which 
does not represent the consensus sequence of the polyadenylation signal 
(Fig. 1; Fig. 2· nucleotide position 3347 to 3352). 
Recently, it was suggested that the pentanucleotide sequence AUUUA in the 
3' region of mRNAs is involved in mRNA degradation (33). This sequence was 
mainly found in mRNAs that encode growth factors such as lymphokines and 
cytokines (33). The sequence can be present in multiple copies. For in­
stance, human interleukin-3 contains 6 copies (L. Dorssers, pers. comm.). 
The 3' region of the feline c-sis transcript appeared to contain 3 copies of 
this sequence (Fig. 2: nucleotide positions 2997, 3301 and 331lO. The 
direct involvement of these sequences in sis mRNA degradation remains to be 
established. 
Identification of the cap site. 
To define precisely the 5' end of the human and feline sis transcripts, 
nuclease SI protection experiments were performed using mRNA from specimens 
of feline term placenta or human PC3 mRNA. A 235 bp AluI/AluI DNA fragment 
(A53: Fig. 2: nucleotide position -13 to 222 of feline c-sis) and a 243 bp 
AluI/AluI DNA fragment (АЧЧ; nucleotide position 391 to 633 of human c-sis 
(13)) were used in these studies. Fig. 4 shows the results of the nuclease 
SI digestion of hybrids between feline placenta RNA and A53 DNA (purified 
insert) and between PC3 mRNA and АЧЧ DNA (purified insert). In analysis of 
the feline sis transcript, a hybrid of 222 nucleotides long appeared to 
represent a major portion of the nuclease SI resistant molecules (Fig. 4, 
lane a). Some other bands were visible on the autoradlographs and they 
represented hybrids of different length. Similar results were obtained in 
nuclease SI experiments with the human sis transcript (Fig. 4, lane b). The 
results suggest that the feline and human sis transcript have their cap 
sites in the same position. The presence of some bands of minor intensity 
on the autoradlographs could be explained as follows. It is possible, that 
more transcription start sites are present. This is more often observed, as 
for instance with transcripts of the genes coding for chicken a2 type I col-
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Ч. Nuclease ^ Sl analysis of the feline and human sis transcripts. (A) Uni-
formily P-labeled insert of A53 was hybridized with feline placenta 
mRNA. Upon treatment of the hybrid with nuclease SI , the product was 
analyzed under denaturing conditions (lane a). The four lanes at left 
show a portion of the nucleotide sequence of A53 to estimate molecular 
weights. (B) Nuclease SI resistant hybrid products of human PC3 mRNA 
and hHk. A portion of nucleotide sequence of АЧЧ is shown at the left. 
lagen, epidermal growth factor receptor and Ύ-crystallins (29,34,35). It is 
also possible that minor fractions of the double stranded hybrids are not 
properly digested by nuclease SI. 
Based upon our data, the cap site of the sis transcript could be placed 
at the adenine residue at the nucleotide position 31 bp downstream of the 
"TATA" box. It was reported that most known eukaryotic mRNAs start with an 
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Fe c - s i a MNRCHALFLSLCCÏLnLVSAECDPIPEELÏKHLSDHSIBSFDDLQRLLHCDSVDEDRAELOLNSTHSHCCGELESLSRCBBSLCEAiCSPTVAE 
Hu c - s l s E POE—G M S A —L- I — 
v-sls MTLTWQ С Q — G K - - C M S A—K — - — L S - - -
Fe С - s i s PAMIAECKTRTEVFEVSRHLIDBTNANFLVWPPCVEVQHCSGCCNNRNVQCRPTQVQLRLVQVRKIEIÏRKRPVFKKATVTLEDHLACKCETVV 
Hu C-s ls 1 Ρ K-I A 
v - s l s 1 Ρ K-I I-A 
Fe C-sls AARPVTRSPGSSeEQRARTPflTRVTIRTVRVRRPPKGKHOKFXHTHDKKALKETLGA 
Hu c - s l s -G К R Τ 
v-sls —-A Τ K-T-S R-C Τ 
5. Comparison of the deduced amino acid sequences of the putative transla-
tional products of feline and human (14) c-sls and of v-sls of SSV (37). 
The arrow ( \ ) Indicates the position of the N-terminus of the human 
PDGF-2 sequence (38). 
adenine residue (36). (The adenine residue at nucleotide position 404 of the 
human c-sis proto-oncogene was mistakenly given as a "C in a previous pub­
lication (13)). Therefore, our results are in good agreement with consensus 
characteristics of a cap site. Recently, Rao et^  al. (16) mapped the cap 
site of the human с-зіз transcript at nucleotide position corresponding to 
position -6 of the feline DNA (Fig. 2). Messenger RNA isolated from human 
placenta and EJ tumor cells were used. In both cases, the same cap site was 
found and was located 25 bp downstream of the "TATA" box. The sequence of 
this cap site and its distance to the "TATA" box are not in good agreement 
with consensus cap site characteristics described by Breathnach and Chambón 
(36). 
DNA insertion in feline c-sis. 
Comparative nucleotide sequence analysis of genomic clones of feline and 
human c-sis, of cDNA clones of the sis transcripts of the two species and of 
the proviral DNA of the oncogene of SSV revealed two interesting differ-
ences. First of all, an insertion of 12 bp was found at the 3' end of exon 
3 (Fig. 2: nucleotide position 1243 to 1254) of the feline c-sis gene. The 
ATG start codon is located at position 993 and the stop codon at position 
1704. Therefore, the insert is present in the region that encodes the PDCF 
domain. To illustrate the effect of the insertion at the protein level, a 
comparison of the putative translational products of the feline, human and 
viral sis genes is shown in Fig. 5. The very high degree of homology is 
clear. The amino-terminus of the human PDGF-2 domain in the precursor is 
given by an arrow. In case the same proteolytic cleavage site is used m 
the feline and the human precursor protein, the 12 bp insertion could pro-
vide feline PDGF-2 with a different NH -terminus. Because of the nature of 
the amino acid sequence of the insertion, the different NH -terminus is not 
very likely to provide feline PDGF-2 with different characteristics. 
Nucleic Acids Research 
It should be noted that the 5' end of the 12 bp insertion resembles the 
consensus sequence of a 3' splice junction. From analysis of our feline 
sis-specific cDNAs it can be concluded that this splice site is not used 
during splicing of feline sis precursor RNA. Theoretically, however, it is 
possible that the cDNAs described in this paper represent only a not fully 
spliced sis precursor RNA. The fact that no cDNAs without the insertion 
were isolated argues against the latter possibility. 
When compared to the v-sis sequences of SSV, an insertion was found at 
the 5' end of exon 7 of the feline с-зіз proto-oncogene (Fig. 2: nucleotide 
position 1753 to 1895). This insertion was also present in the human c-sis 
proto-oncogene. It has been suggested (15) that because of differences in 
splicing of the human and woolly monkey sis precursor RNA, the sequences 
described above are deleted from the woolly monkey sis mRNA. Based upon the 
presence of this region in feline sis-speclf1c cDNA clones, it is more like­
ly that a deletion in the SSV genome occurred during or subsequently to its 
generation. 
From the structure of the human and feline sis transcripts described in 
this paper, a consensus structure for the sis transcription unit can be de­
duced. The data strongly support our assignment of the promoter region that 
controls sis expression. 
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With the discovery of oncogenes in the genome of acutely 
transforming RNA tumorviruses, more insight in the process of 
cancer was obtained. Based upon the function of the products of 
the viral oncogenes their key role in the induction of neoplas-
mas was established. The viral oncogenes show homology with 
cellular genes, called proto-onocogenes, present in the genome 
of probably all eukaryotes. 
At this moment the function of most proto-oncogenes is not 
well established. However, more data become available leading 
to the conclusion that these genes are not only involved in tu-
morigenesis but also in normal cell growth and differentiation. 
In chapter 1, a summary is given of some cellular processes 
following the binding of a growth factor to its receptor. This 
summary is given because one chain of platelet-derived growth 
factor (PDGF-2) is encoded by the sis proto-oncogene. This 
proto-oncogene is the topic in this thesis. At the end of this 
chapter some general (molecular) biological aspects of PDGF and 
the sis proto-oncogene are presented. 
In chapter 2, a description of the isolation and characteri-
zation of the human and feline c-sis proto-oncogenes is given. 
Screening of human and feline cosmid libraries with a v-sis 
specific probe resulted in the isolation of several human and 
feline c-sis containing cosmid clones which led to the isola-
tion of the complete c-sis sequences. By comparative analysis 
of the human and feline cosmid clones the identification was 
achieved of a new 5' c-sis exon (exon 1) which was not present 
in the viral sis oncogene. 
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In chapter 3, the nucleotide sequence of exon 1 of the human 
and feline c-sis proto-oncogenes and their flanking sequences 
was studied. 4 promoter region ("TATA" box) and consensus se-
quences for Spi binding sites were found in similar positions 
in the c-sis proto-oncogenes of both species. It appeared that 
the sequences of exon 1 were conserved and included the ATG 
startcodon. 
Regions upstream and downstream of the c-sis proto-oncogenes 
appeared also to be conserved. They contain possibly repetitive 
sequences which, however, do not belong to the category of 
highly repetitive sequences. 
Whereas PDGF consists of two polypeptide chains, only one 
chain (PDGF-2) was identified in the c-sis containing cosmid 
clones, since a synthetic mixed oligonucleotide probe for 
PDGF-1 failed to detect homologous sequences. 
In chapter H, the complete nucleotide sequence of the feline 
c-sis exons is presented. Using nuclease SI assays and cDNA 
cloning experiments, the cap site and poly(A)-addition site of 
the human and feline c-sis proto-oncogenes were determined. The 
sis transcripts of these two species, which are similar in size 
(3-5 kb), show a strong conservation of their 5' and 3' ends. 
Comparative analysis of the deduced translational products 
of the human, feline and viral sis genes leads to the conclu-
sion that these products are highly conserved. However, at the 
amino-terminal end of the feline PDGF-2 an insertion of 4 amino 
acids is present. Because of the nature of these amino acids it 
is not likely that feline PDGF has very different characteris-
tics than human PDGF. 
Compared to the v-sis sequences of simian sarcoma virus 
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(SSV), the human and feline c-sis proto-oncogenes contain an 
insertion at the 5' end of exon 7. This deletion in the SSV 
genome is likely occurred during or subsequently to the genera-
tion of SSV. 
Expression of c-sis is observed in a number of cell types 
and, in some cases, expression is modulated during cell dif-
ferentiation. The biological reagents that are developped in 
the research project described in this thesis make it possible 
to study this modulation in c-sis expression and to define the 
nucleotide sequences that control these processes. 
77 
SAMENVATTING 
Met de ontdekking van de aanwezigheid van oncogenen in het 
genoom van acuut transformerende RNA tumor virussen werd een 
grote stap voorwaarts gemaakt in het verkrijgen van inzicht in 
het ontstaan van kanker. De eiwitprodukten van de oncogenen 
blijken een sleutelrol te spelen in de inductie van neoplasmas. 
Deze virale oncogenen vertonen homologie met cellulaire genen, 
zogenaamde proto-oncogenen, aanwezig in het genoom van waar-
schijnlijk alle eukaryoten. 
De funktie van de meeste proto-oncogenen is nog niet precies 
bekend. Er zijn echter sterke aanwijzingen dat deze genen be-
trokken zijn bij zowel de vorming van tumoren als in het groei-
en differentiatieproces. 
Tn hoofdstuk 1 wordt een overzicht gegeven van enkele pro-
cessen in de cel die volgen op de binding van een groeifaktor 
aan zijn receptor. Dit overzicht is hier opgenomen omdat een 
van de ketens van platelet-derived growth factor (PDGF-2) 
gecodeerd wordt door het sis proto-oncogen, het gen dat in dit 
proefschrift centraal staat. Tot slot worden enkele algemene 
(moleculair) biologische aspecten van PDGF en het sis proto-
oncogen gepresenteerd. 
In hoofdstuk 2 wordt de isolatie en karakterisatie van het 
humane en katte c-sis proto-oncogen beschreven. Door gebruik te 
maken van cosmide banken, welke gemaakt zijn met behulp van 
humaan en katte chromosomaal DNA, en een v-sis specifieke 
probe, werden diverse c-sis bevattende cosmide clonen 
geïsoleerd. Dit resulteerde in de clonering van de totale 
humane en katte c-sis proto-oncogen sekwenties. Vergelijkende 
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studies van deze cosmide clonen leidden tot de beschrijving van 
een nieuw 5' gelegen exon (=exon 1), dat niet aanwezig was in 
het virale sis oncogen. 
In hoofdstuk 3 worden de sekwenties van exon 1 en zijn 
omgeving getoond zowel van het humane als het katte c-sis 
proto-oncogen. Een "TATA" box en consensus sekwenties voor Spi 
bindingsplaatsen zijn in het humane en in het katte c-sis 
proto-oncogen op identieke plaatsen gelegen. Verder bleek uit 
deze studie dat exon 1 sterk geconserveerd was en dat het 
startcodon voor de translatie in dit exon gelegen was. 
Ook gebieden buiten het c-sis proto-oncogen bleken tussen 
mens en kat sterk geconserveerd te zijn. Mogelijk bevatten zij 
repeterende sekwenties. Deze behoren echter niet tot de klasse 
van vaak voorkomende repeterende sekwenties. 
Door gebruik te maken van een gemengde synthetische oligonu­
cleotide probe werd aangetoond dat in de humane c-sis bevat­
tende cosmide clonen geen sekwenties aanwezig waren die zouden 
kunnen coderen voor de andere keten van PDGF (PDGF-1). 
In hoofdstuk Ц wordt de volledige exon sekwentie van het 
katte c-sis proto-oncogen gepresenteerd. Met behulp van nu­
clease SI assays en cDNA cloneringen werden respectievelijk de 
zgn. cap site en poly(A)-additie site in zowel het humane als 
katte c-sis proto-oncogen geplaatst. Hieruit bleek dat zowel 
het 5' als 3' uiteinde van het c-sis gen sterk geconserveerd 
waren tussen deze species. Het geconserveerde karakter van het 
c-sis gen kwam ook tot uitdrukking in de grootte van het sis 
mRNA: 3-5 kb voor zowel het humane als katte mRNA. 
Uit de vergelijking van de theoretische translatie Produkten 
van het humane, katte en virale sis gen volgde de conclusie dat 
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ook de eiwitprodukten geconserveerd zijn. Echter, aan het 
amino-terminale uiteinde van PDGF-2 is bij de kat een insertie 
van 4 aminozuren gevonden. Vanwege de aard van deze extra ami-
nozuren lijkt het niet waarschijnlijk dat PDGF van de kat sterk 
verschillende eigenschappen zou hebben dan humaan PDGF. 
Uit de vergelijking van de DNA sekwenties van de humane en 
katte c-sis genen enerzijds en het virale sis gen anderzijds 
werd duidelijk dat aan het 5' einde van exon 7 bij zowel het 
humane als het katte gen extra sekwenties aanwezig waren. 
Hoogstwaarschijnlijk zijn deze sekwenties gedurende de vorming 
van het simian sarcoma virus, dat het v-sis oncogen bevat, vei— 
loren gegaan. 
Uit deze studie naar het c-sis proto-oncogen blijkt dat dit 
gen tussen mens en kat sterk geconserveerd is, zelfs buiten de 
exon sekwenties. Met behulp van de gegevens in dit proef-
schrift kunnen verdere studies naar de regulatie van de expres-
sie van het sis proto-oncogen verricht worden. 
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1. De conclusie dat epidermale cellen gevoeliger zijn voor UVA 
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een muize-keratinocyten-cellijn met die van een menselijke 
epitheliale carcinoma-eellijn. 
Laskin et ab (1986) Proc. Natl. Acad. Sci. USA 83, 8211-
8215 
2. De onzekerheid bij Rao et al. inzake de positie van de 
poly(A)-additie plaats in het menselijke c-sls proto-
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